Legislator
Legislator > LaTonya Johnson
State Senator
LaTonya Johnson
(D) - Wisconsin
Wisconsin Senate District 06
In Office - Started: 01/02/2017
contact info
Capitol Office
P.O. Box 7882
State Capitol, 2 E. Main St.
Madison, WI 53707
State Capitol, 2 E. Main St.
Madison, WI 53707
Phone: 608-266-2500
Phone 2: 877-474-2000
District Office Phone
, WI
Phone: 414-313-1241
| Bill | Bill Name | Summary | Progress |
|---|---|---|---|
| AB250 | Funding for the War Memorial Center and making an appropriation. (FE) | Under current law, by agreement between the county board and any nonprofit private corporation, a county having a population of 750,000 or more may establish and maintain a memorial to commemorate the lives and deeds of persons who served the state or nation in war or other national service. Milwaukee County is the only county in the state with a population of 750,000 or more, and the county established and maintains a memorial called the War Memorial Center. This bill creates a continuing appropriation account for the Department of Veterans Affairs from which the War Memorial Center[s memorial board may request DVA to provide funds to it for support of the memorial. In making a request for the funds, the memorial board is required to describe its intended use of the funds, and to aver that it has secured equal matching funds that it will contribute to its intended project supporting the War Memorial Center. In addition, in each fiscal year in which the War Memorial Center[s memorial board receives funds from DVA as described under the bill, the War Memorial Center[s memorial board is required to submit a report to the Joint Committee on Finance that describes how the funds were used and that indicates how much money remains in the appropriation account. For further information see the state and local fiscal estimate, which will be printed as an appendix to this bill. | In Committee |
| SB264 | Coverage of breast cancer screenings by the Medical Assistance program and health insurance policies and plans. (FE) | This bill requires health insurance policies to provide coverage for diagnostic breast examinations and for supplemental breast screening examinations for an individual who is at increased risk of breast cancer, as determined in accordance with the most recent applicable guidelines of the National Comprehensive Cancer Network, or has heterogeneously or extremely dense breast tissue, as defined by the Breast Imaging-Reporting and Data System established by the American College of Radiology. Health insurance policies are referred to in the statutes as disability insurance policies. Self-insured governmental health plans are also required to LRB-3021/1 JPC&SWB:cdc 2025 - 2026 Legislature SENATE BILL 264 provide the coverage specified in the bill. The bill also requires coverage of those breast screenings by the Medical Assistance program, which is the state- administered Medicaid program that is jointly funded by the state and federal governments and that provides health services to individuals with limited financial resources. Under the bill, health insurance policies may not charge a cost-sharing amount for a supplemental breast screening examination or diagnostic breast examination. The limitation on cost-sharing does not apply to the extent that the limitation would result in ineligibility for a health savings account under the federal Internal Revenue Code. Health insurance policies are required under current law to cover two mammographic breast examinations to screen for breast cancer for a woman from ages 45 to 49 if certain criteria are satisfied. Health insurance policies must currently cover annual mammograms for a woman once she attains the age of 50. The coverage required under current law is required whether or not the woman shows any symptoms of breast cancer and may be subject to only the same exclusions and limitations, including cost sharing, that apply to other radiological examinations under the policy. The bill does not change or eliminate the current coverage requirements for mammograms, except that preferred provider plans are explicitly included in the current law and the bill[s requirements. This proposal may contain a health insurance mandate requiring a social and financial impact report under s. 601.423, stats. For further information see the state fiscal estimate, which will be printed as an appendix to this bill. | In Committee |
| SB321 | Adopting gender-neutral terminology and incorporating gender-neutral marriage and parentage rights. (FE) | Summary This bill recognizes same-sex marriage by making references in the statutes to spouses gender-neutral, with the intent of harmonizing the Wisconsin Statutes with the holding of the U.S. Supreme Court in Obergefell v. Hodges, 135 S. Ct. 2584, 192 L. Ed. 2d 609 (2015), which recognizes that same-sex couples have a fundamental constitutional right to marriage. The bill also recognizes legal parentage for same-sex couples under certain circumstances and adopts gender- neutral parentage terminology. Same-sex marriage The bill provides that marriage may be contracted between persons of the same sex and confers the same rights and responsibilities on married persons of the same sex that married persons of different sexes have under current law. The bill LRB-0842/1 MDE:cjs 2025 - 2026 Legislature SENATE BILL 321 defines XspouseY as a person who is legally married to another person of the same sex or a different sex and replaces every reference to XhusbandY or XwifeY in current law with Xspouse.Y The bill makes applicable to married persons of the same sex all provisions under current law that apply to married persons of different sexes. These provisions relate to such diverse areas of the law as income tax, marital property, inheritance rights, divorce, child and spousal support, insurance coverage, family and spousal recreational licenses, consent to conduct an autopsy, domestic abuse, and eligibility for various types of benefits, such as retirement or death benefits and medical assistance. Parentage In addition to making statutory references to spouses gender-neutral, the bill specifies ways in which couples of the same sex may be the legal parents of a child, recognizes that a transgender person may become pregnant and give birth to a child, and makes current references in the statutes to XmotherY and Xfather,Y and related terms, gender-neutral. Under current law, all of the following may adopt a child: a husband and wife jointly, a husband or wife whose spouse is the parent of the child, and an unmarried adult. Because the bill makes references in the statutes to spouses gender-neutral, same-sex spouses jointly may adopt a child and become the legal parents of the child, and a same-sex spouse of a person who is the parent of a minor child may adopt the child and become the legal parent of his or her spouse[s child. Under current law, if a woman is artificially inseminated under the supervision of a physician with semen donated by a man who is not her husband and the husband consents in writing to the artificial insemination of his wife, the husband is the natural father of any child conceived. Under the bill, one spouse may also consent to the artificial insemination of his or her spouse and is the natural parent of the child conceived. The artificial insemination is not required to take place under the supervision of a physician, but, if it does not, the semen used for the insemination must have been obtained from a sperm bank. Under current law, a man is presumed to be the father of a child if he and the child[s natural mother 1) were married to each other when the child was conceived or born or 2) married each other after the child was born but had a relationship with each other when the child was conceived and no other man has been adjudicated to be the father or is presumed to be the father because the man was married to the mother when the child was conceived or born. The paternity presumption may be rebutted in a legal action or proceeding by the results of a genetic test showing that the statistical probability of another man[s parentage is 99.0 percent or higher. The bill expands this presumption into a parentage presumption, so that a person is presumed to be the natural parent of a child if he or she 1) was married to the person who gave birth to the child when the child was conceived or born or 2) married the person who gave birth to the child after the child was born but had a relationship with the person who gave birth to the child when the child was conceived and no person has been adjudicated to be the child[s LRB-0842/1 MDE:cjs 2025 - 2026 Legislature SENATE BILL 321 parent and no other person is presumed to be the child[s parent because he or she was married, at the time the child was born, to the person who gave birth to the child. The parentage presumption may still be rebutted by the results of a genetic test showing that the statistical probability of another person[s parentage is 99.0 percent or higher. Expanding on current law, the bill allows for a parentage action to be brought for the purpose of rebutting the parentage presumption, regardless of whether that presumption applies to a male or female spouse. Current law provides that a mother and a man may sign a statement acknowledging paternity and file it with the state registrar. If the state registrar has received such a statement, the man is presumed to be the father of the child. Under current law, either person who has signed a statement acknowledging paternity may rescind the statement before an order is filed in an action affecting the family concerning the child or within 60 days after the statement is filed, whichever occurs first. Under current law, a man who has filed a statement acknowledging paternity that is not rescinded within the time period is conclusively determined to be the father of the child. The bill provides that two people, one of whom gave birth to the child, may sign a statement acknowledging parentage and file it with the state registrar. If the state registrar has received such a statement, the people who have signed the statement are presumed to be the parents of the child. Under the bill, a statement acknowledging parentage that is not rescinded conclusively establishes parentage with regard to the person who did not give birth to the child and who signed the statement. Under current law, the paternity of a child may be established by genetic testing in an administrative determination of paternity or in a paternity action in court. The bill changes the term XpaternityY to XparentageY in the context of establishing the parent of a child by genetic testing. The bill defines Xnatural parentY as a parent of a child who is not an adoptive parent, whether the parent is biologically related to the child or not. Thus, a person who is a biological parent, a parent by consenting to the artificial insemination of his or her spouse, or a parent under the parentage presumption is a natural parent of a child. The definition applies throughout the statutes wherever the term Xnatural parentY is used. In addition, the bill expands some references in the statutes to Xbiological parentY by changing the reference to Xnatural parent.Y Birth certificates Generally, the bill substitutes the term XspouseY for XhusbandY in the birth certificate statutes and enters the spouse, instead of the husband, of the person who has given birth on the birth certificate at times when a husband would currently be entered on a birth certificate. The name of the person who has given birth is entered on a birth certificate when the person gives birth to a child, and current law specifies when another name should be entered on the birth certificate. Current law requires that if a birth mother is married at any time from the conception to the birth of a child, then her husband[s name is entered on the birth certificate as the legal father of the child. Under the bill, if a person who gives birth is married at any LRB-0842/1 MDE:cjs 2025 - 2026 Legislature SENATE BILL 321 time from the conception to the birth of the child, then that person[s spouse[s name is entered as a legal parent of the child. The bill also specifies that, in the instance that a second parent[s name is initially omitted from the birth certificate, if the state registrar receives a signed acknowledgement of parentage by people presumed to be parents because the two people married after the birth of the child, the two people had a relationship during the time the child was conceived, no person is adjudicated to be the father, and no other person is presumed to be the parent, then the state registrar must enter the name of the spouse of the person who gave birth as a parent on the birth certificate. Because this bill relates to an exemption from state or local taxes, it may be referred to the Joint Survey Committee on Tax Exemptions for a report to be printed as an appendix to the bill. For further information see the state and local fiscal estimate, which will be printed as an appendix to this bill. | In Committee |
| SJR70 | Proclaiming June 12, 2025, as Women Veterans Day. | Relating to: proclaiming June 12, 2025, as Women Veterans Day. | Crossed Over |
| SB330 | Waiting period for purchase of handguns. | Current law provides that, before a federally licensed firearms dealer may transfer a handgun after a sale, the dealer must request that the Department of Justice perform a background check on the prospective purchaser to determine if the purchaser is prohibited from possessing a firearm. This bill prohibits the dealer from transferring the handgun to the purchaser until 48 hours have passed since the firearms dealer requested the background check on the purchaser. | In Committee |
| SB332 | Prohibition against undetectable firearms, possessing a frame or receiver of a firearm without a serial number, and providing a penalty. | This bill prohibits the manufacture, transportation, sale, possession, and carrying of firearms that cannot be detected by metal detectors or airport x-ray machines or scanners. Federal law currently has a comparable prohibition; under this bill, the person would violate state law as well. A person who violates the state prohibition is guilty of a Class G felony. This bill also prohibits the sale, posting, provision, or possession of plans for manufacturing an undetectable firearm. A person who violates this prohibition is guilty of a Class H felony. Finally, the bill prohibits the possession of a frame or a receiver of a firearm that is not marked with a serial number. A person who violates this prohibition is guilty of a Class I felony. Because this bill creates a new crime or revises a penalty for an existing crime, LRB-3489/1 CMH:klm 2025 - 2026 Legislature SENATE BILL 332 the Joint Review Committee on Criminal Penalties may be requested to prepare a report. | In Committee |
| SB336 | Sales and transfers of firearms and providing a penalty. (FE) | Current law provides that a federally licensed firearms dealer may not LRB-1276/1 CMH:klm 2025 - 2026 Legislature SENATE BILL 336 transfer a handgun after a sale until the dealer has performed a background check on the prospective transferee to determine if he or she is prohibited from possessing a firearm under state or federal law. This bill generally prohibits any person from transferring any firearm, including the frame or receiver of a firearm, unless the transfer occurs through a federally licensed firearms dealer and involves a background check of the prospective transferee. Under the bill, the following are excepted from that prohibition: a transfer to a firearms dealer or to a law enforcement or armed services agency; a transfer of a firearm classified as antique; or a transfer that is by gift, bequest, or inheritance to a family member. A person who is convicted of violating the prohibition is guilty of a misdemeanor and must be fined not less than $500 nor more than $10,000, may be imprisoned for not more than nine months, and may not possess a firearm for a period of two years. Because this bill creates a new crime or revises a penalty for an existing crime, the Joint Review Committee on Criminal Penalties may be requested to prepare a report. For further information see the state fiscal estimate, which will be printed as an appendix to this bill. | In Committee |
| SJR73 | Recognizing June 2025 as LGBTQ Pride Month. | Relating to: recognizing June 2025 as LGBTQ Pride Month. | In Committee |
| SB329 | Extreme risk protection temporary restraining orders and injunctions, making an appropriation, and providing a penalty. (FE) | Under current law, a person is prohibited from possessing a firearm, and must surrender all firearms, if the person is subject to a domestic abuse injunction, a child abuse injunction, or, in certain cases, a harassment or an individuals-at-risk injunction. If a person surrenders a firearm because the person is subject to one of those injunctions, the firearm may not be returned to the person until a court determines that the injunction has been vacated or has expired and that the person is not otherwise prohibited from possessing a firearm. A person who is prohibited from possessing a firearm under such an injunction is guilty of a Class G felony for violating the prohibition. This bill creates an extreme risk protection temporary restraining order and injunction to prohibit a person from possessing a firearm. Under the bill, either a law enforcement officer or a family or household member of the person may file a LRB-3517/1 CMH:cdc 2025 - 2026 Legislature SENATE BILL 329 petition with a court to request an extreme risk protection injunction. The petition must allege facts that show that the person is substantially likely to injure themself or another if the person possesses a firearm. Under the bill, the petitioner may request the court to consider first granting a temporary restraining order. If the petitioner requests a TRO, the petitioner must include evidence that there is an immediate and present danger that the person may injure themself or another if the person possesses a firearm and that waiting for the injunction hearing increases the immediate and present danger. If the petitioner requests a TRO, the court must hear the petition in an expedited manner. The judge must issue a TRO if, after questioning the petitioner and witnesses or relying on affidavits, the judge determines that it is substantially likely that the petition for an injunction will be granted and the judge finds good cause to believe there is an immediate and present danger that the person will injure themself or another if the person has a firearm and that waiting for the injunction hearing may increase the immediate and present danger. If the judge issues a TRO, the TRO is in effect until the injunction hearing, which must occur within 14 days of the TRO issuance. The TRO must require a law enforcement officer to personally serve the person with the order and to require the person to immediately surrender all firearms in their possession. If a law enforcement officer is unable to personally serve the person, then the TRO requires the person to surrender within 24 hours all firearms to a law enforcement officer or a firearms dealer and to provide the court a receipt indicating the surrender occurred. At the injunction hearing, the court may grant an extreme risk protection injunction ordering the person to refrain from possessing a firearm and, if the person was not subject to a TRO, to surrender all firearms he or she possesses if the court finds by clear and convincing evidence that the person is substantially likely to injure themself or another if the person possesses a firearm. An extreme risk protection injunction is effective for up to one year and may be renewed. A person who is subject to an extreme risk protection injunction may petition to vacate the injunction. If a person surrenders a firearm because the person is subject to an extreme risk protection TRO or injunction, the firearm may not be returned to the person until a court determines that the TRO has expired or the injunction has been vacated or has expired and that the person is not otherwise prohibited from possessing a firearm. A person who possesses a firearm while subject to an extreme risk protection TRO or injunction is guilty of a Class G felony. In addition, a person who files a petition for an extreme risk protection injunction, knowing the information in the petition to be false, is guilty of the crime of false swearing, a Class H felony. The bill also requires the Department of Administration to award grants to law enforcement agencies for the purpose of training officers how to identify persons who are substantially likely to injure themselves or another if the person possesses a firearm and how to file a petition for an extreme risk protection TRO or injunction. LRB-3517/1 CMH:cdc 2025 - 2026 Legislature SENATE BILL 329 Because this bill creates a new crime or revises a penalty for an existing crime, the Joint Review Committee on Criminal Penalties may be requested to prepare a report. For further information see the state and local fiscal estimate, which will be printed as an appendix to this bill. | In Committee |
| SB145 | The procedure for adding federal newborn screening recommendations to the state-required newborn screenings, granting rule-making authority, and providing an exemption from emergency rule procedures. (FE) | In general, under current law, newborns must be tested for certain congenital and metabolic disorders as specified in rules promulgated by the Department of Health Services. The federal Department of Health and Human Services maintains a list of disorders for which it recommends testing in newborns, known as the federal Recommended Uniform Screening Panel (RUSP). Under this bill, DHS must evaluate each disorder that is included in the RUSP as of January 1, 2025, to determine whether newborns in this state should be tested for that disorder. This requirement does not apply to any disorder in the RUSP if, as of January 1, 2025, the disorder is already included in the list of disorders for which newborns must be tested in this state. In addition, the bill requires DHS to evaluate any disorder added to the RUSP after January 1, 2025, to determine whether newborns in this state should be tested for that newly added disorder. If DHS determines newborns should not be tested for the disorder, DHS must annually review medical literature and the department[s capacity and resources to LRB-1271/1 KMS:cdc 2025 - 2026 Legislature SENATE BILL 145 test for the disorder in order to determine whether to reevaluate the inclusion of the disorder in newborn testing in this state. If, in any of these evaluations or reevaluations, DHS determines that a disorder in the RUSP should be added to the list of disorders for which newborns must be tested in this state, the bill requires DHS to promulgate rules to add that disorder. The requirements for evaluations, reviews, and reevaluations under the bill do not apply to a disorder in the RUSP if DHS is in the process of adding, by rule, the disorder to the list of disorders for which newborns must be tested in this state. However, if the rule-making procedure for that disorder does not result in promulgation of a rule, then DHS must consider the disorder under the review and reevaluation procedures under the bill. For further information see the state fiscal estimate, which will be printed as an appendix to this bill. | In Committee |
| SJR34 | Honoring the 50th anniversary of the child support program. | Relating to: honoring the 50th anniversary of the child support program. | Crossed Over |
| AB314 | Adopting gender-neutral terminology and incorporating gender-neutral marriage and parentage rights. (FE) | Summary This bill recognizes same-sex marriage by making references in the statutes to spouses gender-neutral, with the intent of harmonizing the Wisconsin Statutes with the holding of the U.S. Supreme Court in Obergefell v. Hodges, 135 S. Ct. 2584, 192 L. Ed. 2d 609 (2015), which recognizes that same-sex couples have a fundamental constitutional right to marriage. The bill also recognizes legal parentage for same-sex couples under certain circumstances and adopts gender- neutral parentage terminology. Same-sex marriage The bill provides that marriage may be contracted between persons of the same sex and confers the same rights and responsibilities on married persons of the same sex that married persons of different sexes have under current law. The bill defines XspouseY as a person who is legally married to another person of the same sex or a different sex and replaces every reference to XhusbandY or XwifeY in current law with Xspouse.Y The bill makes applicable to married persons of the same sex all provisions under current law that apply to married persons of different sexes. These provisions relate to such diverse areas of the law as income tax, marital property, inheritance rights, divorce, child and spousal support, insurance coverage, family and spousal recreational licenses, consent to conduct an autopsy, domestic abuse, and eligibility for various types of benefits, such as retirement or death benefits and medical assistance. Parentage In addition to making statutory references to spouses gender-neutral, the bill specifies ways in which couples of the same sex may be the legal parents of a child, recognizes that a transgender person may become pregnant and give birth to a child, and makes current references in the statutes to XmotherY and Xfather,Y and related terms, gender-neutral. Under current law, all of the following may adopt a child: a husband and wife jointly, a husband or wife whose spouse is the parent of the child, and an unmarried adult. Because the bill makes references in the statutes to spouses gender-neutral, same-sex spouses jointly may adopt a child and become the legal parents of the child, and a same-sex spouse of a person who is the parent of a minor child may adopt the child and become the legal parent of his or her spouse[s child. Under current law, if a woman is artificially inseminated under the supervision of a physician with semen donated by a man who is not her husband and the husband consents in writing to the artificial insemination of his wife, the husband is the natural father of any child conceived. Under the bill, one spouse may also consent to the artificial insemination of his or her spouse and is the natural parent of the child conceived. The artificial insemination is not required to take place under the supervision of a physician, but, if it does not, the semen used for the insemination must have been obtained from a sperm bank. Under current law, a man is presumed to be the father of a child if he and the child[s natural mother 1) were married to each other when the child was conceived or born or 2) married each other after the child was born but had a relationship with each other when the child was conceived and no other man has been adjudicated to be the father or is presumed to be the father because the man was married to the mother when the child was conceived or born. The paternity presumption may be rebutted in a legal action or proceeding by the results of a genetic test showing that the statistical probability of another man[s parentage is 99.0 percent or higher. The bill expands this presumption into a parentage presumption, so that a person is presumed to be the natural parent of a child if he or she 1) was married to the person who gave birth to the child when the child was conceived or born or 2) married the person who gave birth to the child after the child was born but had a relationship with the person who gave birth to the child when the child was conceived and no person has been adjudicated to be the child[s parent and no other person is presumed to be the child[s parent because he or she was married, at the time the child was born, to the person who gave birth to the child. The parentage presumption may still be rebutted by the results of a genetic test showing that the statistical probability of another person[s parentage is 99.0 percent or higher. Expanding on current law, the bill allows for a parentage action to be brought for the purpose of rebutting the parentage presumption, regardless of whether that presumption applies to a male or female spouse. Current law provides that a mother and a man may sign a statement acknowledging paternity and file it with the state registrar. If the state registrar has received such a statement, the man is presumed to be the father of the child. Under current law, either person who has signed a statement acknowledging paternity may rescind the statement before an order is filed in an action affecting the family concerning the child or within 60 days after the statement is filed, whichever occurs first. Under current law, a man who has filed a statement acknowledging paternity that is not rescinded within the time period is conclusively determined to be the father of the child. The bill provides that two people, one of whom gave birth to the child, may sign a statement acknowledging parentage and file it with the state registrar. If the state registrar has received such a statement, the people who have signed the statement are presumed to be the parents of the child. Under the bill, a statement acknowledging parentage that is not rescinded conclusively establishes parentage with regard to the person who did not give birth to the child and who signed the statement. Under current law, the paternity of a child may be established by genetic testing in an administrative determination of paternity or in a paternity action in court. The bill changes the term XpaternityY to XparentageY in the context of establishing the parent of a child by genetic testing. The bill defines Xnatural parentY as a parent of a child who is not an adoptive parent, whether the parent is biologically related to the child or not. Thus, a person who is a biological parent, a parent by consenting to the artificial insemination of his or her spouse, or a parent under the parentage presumption is a natural parent of a child. The definition applies throughout the statutes wherever the term Xnatural parentY is used. In addition, the bill expands some references in the statutes to Xbiological parentY by changing the reference to Xnatural parent.Y Birth certificates Generally, the bill substitutes the term XspouseY for XhusbandY in the birth certificate statutes and enters the spouse, instead of the husband, of the person who has given birth on the birth certificate at times when a husband would currently be entered on a birth certificate. The name of the person who has given birth is entered on a birth certificate when the person gives birth to a child, and current law specifies when another name should be entered on the birth certificate. Current law requires that if a birth mother is married at any time from the conception to the birth of a child, then her husband[s name is entered on the birth certificate as the legal father of the child. Under the bill, if a person who gives birth is married at any time from the conception to the birth of the child, then that person[s spouse[s name is entered as a legal parent of the child. The bill also specifies that, in the instance that a second parent[s name is initially omitted from the birth certificate, if the state registrar receives a signed acknowledgement of parentage by people presumed to be parents because the two people married after the birth of the child, the two people had a relationship during the time the child was conceived, no person is adjudicated to be the father, and no other person is presumed to be the parent, then the state registrar must enter the name of the spouse of the person who gave birth as a parent on the birth certificate. Because this bill relates to an exemption from state or local taxes, it may be referred to the Joint Survey Committee on Tax Exemptions for a report to be printed as an appendix to the bill. For further information see the state and local fiscal estimate, which will be printed as an appendix to this bill. | In Committee |
| AB263 | Coverage of breast cancer screenings by the Medical Assistance program and health insurance policies and plans. (FE) | This bill requires health insurance policies to provide coverage for diagnostic breast examinations and for supplemental breast screening examinations for an individual who is at increased risk of breast cancer, as determined in accordance with the most recent applicable guidelines of the National Comprehensive Cancer Network, or has heterogeneously or extremely dense breast tissue, as defined by the Breast Imaging-Reporting and Data System established by the American College of Radiology. Health insurance policies are referred to in the statutes as disability insurance policies. Self-insured governmental health plans are also required to provide the coverage specified in the bill. The bill also requires coverage of those breast screenings by the Medical Assistance program, which is the state- administered Medicaid program that is jointly funded by the state and federal governments and that provides health services to individuals with limited financial resources. Under the bill, health insurance policies may not charge a cost-sharing amount for a supplemental breast screening examination or diagnostic breast examination. The limitation on cost-sharing does not apply to the extent that the limitation would result in ineligibility for a health savings account under the federal Internal Revenue Code. Health insurance policies are required under current law to cover two mammographic breast examinations to screen for breast cancer for a woman from ages 45 to 49 if certain criteria are satisfied. Health insurance policies must currently cover annual mammograms for a woman once she attains the age of 50. The coverage required under current law is required whether or not the woman shows any symptoms of breast cancer and may be subject to only the same exclusions and limitations, including cost sharing, that apply to other radiological examinations under the policy. The bill does not change or eliminate the current coverage requirements for mammograms, except that preferred provider plans are explicitly included in the current law and the bill[s requirements. This proposal may contain a health insurance mandate requiring a social and financial impact report under s. 601.423, stats. For further information see the state fiscal estimate, which will be printed as an appendix to this bill. | In Committee |
| AB61 | Injuring or killing a police or fire animal and providing a penalty. | Under current law, no person may do any of the following to any animal that is used by a law enforcement agency or fire department to perform agency or department functions or duties: frighten, intimidate, threaten, abuse, or harass the animal; strike, shove, kick, or otherwise subject the animal to physical contact; or strike the animal by using a dangerous weapon. Under current law, any person who intentionally does any of those actions and causes injury to the animal is guilty of a Class I felony, and any person who intentionally does any of those actions and causes death of the animal is guilty of a Class H felony. Additionally, for such a violation, a sentencing court must require a criminal violator to pay restitution, including veterinary care expenses or the value of a replacement animal. This bill increases the penalty for injuring such an animal to a Class H felony and the penalty for causing the death of such an animal to a Class G felony. A Class H felony is punishable by a fine of up to $10,000 or imprisonment for up to six years, or both, and a Class G felony is punishable by a fine of up to $25,000 or imprisonment for up to 10 years, or both. Because this bill creates a new crime or revises a penalty for an existing crime, the Joint Review Committee on Criminal Penalties may be requested to prepare a report. | Passed |
| SB64 | Injuring or killing a police or fire animal and providing a penalty. | Under current law, no person may do any of the following to any animal that is used by a law enforcement agency or fire department to perform agency or department functions or duties: frighten, intimidate, threaten, abuse, or harass the animal; strike, shove, kick, or otherwise subject the animal to physical contact; or strike the animal by using a dangerous weapon. Under current law, any person who intentionally does any of those actions and causes injury to the animal is guilty of a Class I felony, and any person who intentionally does any of those actions and causes death of the animal is guilty of a Class H felony. Additionally, for such a violation, a sentencing court must require a criminal violator to pay restitution, including veterinary care expenses or the value of a replacement animal. This bill increases the penalty for injuring such an animal to a Class H felony and the penalty for causing the death of such an animal to a Class G felony. A Class H felony is punishable by a fine of up to $10,000 or imprisonment for up to six years, or both, and a Class G felony is punishable by a fine of up to $25,000 or imprisonment for up to 10 years, or both. Because this bill creates a new crime or revises a penalty for an existing crime, LRB-2029/1 MJW:skw 2025 - 2026 Legislature SENATE BILL 64 the Joint Review Committee on Criminal Penalties may be requested to prepare a report. | In Committee |
| AB145 | Passing legislation to reduce carbon emissions. | This bill requires the legislature, during the 2025-26 legislative session, to pass legislation creating a viable plan to reduce carbon emissions by 52 percent by 2030 and creating a viable plan for achieving carbon neutral emissions by 2050. Any plan created as required under the bill must maximize the impact of the plan on improving economic and racial equity. | In Committee |
| AJR34 | Honoring the 50th anniversary of the child support program. | Relating to: honoring the 50th anniversary of the child support program. | In Committee |
| SB150 | Passing legislation to reduce carbon emissions. | This bill requires the legislature, during the 2025-26 legislative session, to pass legislation creating a viable plan to reduce carbon emissions by 52 percent by 2030 and creating a viable plan for achieving carbon neutral emissions by 2050. Any plan created as required under the bill must maximize the impact of the plan on improving economic and racial equity. | In Committee |
| AB173 | Regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE) | This bill makes several changes to the regulation of pharmacy benefit managers and their interactions with pharmacies and pharmacists. Under current law, pharmacy benefit managers are generally required to be licensed as a pharmacy benefit manager or an employee benefit plan administrator by the commissioner of insurance. A pharmacy benefit manager is an entity that contracts to administer or manage prescription drug benefits on behalf of an insurer, a cooperative, or another entity that provides prescription drug benefits to Wisconsin residents. Major provisions of the bill are summarized below. Pharmacy benefit manager regulation The bill requires a pharmacy benefit manager to pay a pharmacy or pharmacist a professional dispensing fee at a rate not less than is paid by the state under the Medical Assistance program for each pharmaceutical product that the pharmacy or pharmacist dispenses to an individual. The professional dispensing fee is required to be paid in addition to the amount the pharmacy benefit manager reimburses the pharmacy or pharmacist for the cost of the pharmaceutical product that the pharmacy or pharmacist dispenses. The Medical Assistance program is a joint state and federal program that provides health services to individuals who have limited financial resources. The bill prohibits a pharmacy benefit manager from assessing, charging, or collecting from a pharmacy or pharmacist any form of remuneration that passes from the pharmacy or pharmacist to the pharmacy benefit manager including claim-processing fees, performance-based fees, network-participation fees, or accreditation fees. Further, under the bill, a pharmacy benefit manager may not use any certification or accreditation requirement as a determinant of pharmacy network participation that is inconsistent with, more stringent than, or in addition to the federal requirements for licensure as a pharmacy and the requirements for licensure as a pharmacy provided under state law. The bill requires a pharmacy benefit manager to allow a participant or beneficiary of a pharmacy benefits plan or program that the pharmacy benefit manager serves to use any pharmacy or pharmacist in this state that is licensed to dispense the pharmaceutical product that the participant or beneficiary seeks to obtain if the pharmacy or pharmacist accepts the same terms and conditions that the pharmacy benefit manager establishes for at least one of the networks of pharmacies or pharmacists that the pharmacy benefit manager has established to serve individuals in the state. A pharmacy benefit manager may establish a preferred network of pharmacies or pharmacists and a nonpreferred network of pharmacies or pharmacists; however, under the bill, a pharmacy benefit manager may not prohibit a pharmacy or pharmacist from participating in either type of network provided that the pharmacy or pharmacist is licensed by this state and the federal government and accepts the same terms and conditions that the pharmacy benefit manager establishes for other pharmacies or pharmacists participating in the network that the pharmacy or pharmacist wants to join. Under the bill, a pharmacy benefit manager may not charge a participant or beneficiary of a pharmacy benefits plan or program that the pharmacy benefit manager serves a different copayment obligation or additional fee, or provide any inducement or financial incentive, for the participant or beneficiary to use a pharmacy or pharmacist in a particular network of pharmacies or pharmacists that the pharmacy benefit manager has established to serve individuals in the state. Further, the bill prohibits a pharmacy benefit manager, third-party payer, or health benefit plan from excluding a pharmacy or pharmacist from its network because the pharmacy or pharmacist serves less than a certain portion of the population of the state or serves a population living with certain health conditions. The bill provides that a pharmacy benefit manager may neither prohibit a pharmacy or pharmacist that dispenses a pharmaceutical product from, nor penalize a pharmacy or pharmacist that dispenses a pharmaceutical product for, informing an individual about the cost of the pharmaceutical product, the amount in reimbursement that the pharmacy or pharmacist receives for dispensing the pharmaceutical product, or any difference between the cost to the individual under the individual[s pharmacy benefits plan or program and the cost to the individual if the individual purchases the pharmaceutical product without making a claim for benefits under the individual[s pharmacy benefits plan or program. The bill prohibits any pharmacy benefit manager or any insurer or self- insured health plan from requiring, or penalizing a person who is covered under a health insurance policy or plan for using or for not using, a specific retail, mail- order, or other pharmacy provider within the network of pharmacy providers under the policy or plan. Prohibited penalties include an increase in premium, deductible, copayment, or coinsurance. The bill requires pharmacy benefit managers to remit payment for a claim to a pharmacy or pharmacist within 30 days from the day that the claim is submitted to the pharmacy benefit manager by the pharmacy or pharmacist. Pharmaceutical product reimbursements The bill provides that a pharmacy benefit manager that uses a maximum allowable cost list must include all of the following information on the list: 1) the average acquisition cost of each pharmaceutical product and the cost of the pharmaceutical product set forth in the national average drug acquisition cost data published by the federal centers for medicare and medicaid services; 2) the average manufacturer price of each pharmaceutical product; 3) the average wholesale price of each pharmaceutical product; 4) the brand effective rate or generic effective rate for each pharmaceutical product; 5) any applicable discount indexing; 6) the federal upper limit for each pharmaceutical product published by the federal centers for medicare and medicaid services; pharmaceutical product; and 8) any other terms that are used to establish the maximum allowable costs. The bill provides that a pharmacy benefit manager may place or continue a particular pharmaceutical product on a maximum allowable cost list only if the pharmaceutical product 1) is listed as a drug product equivalent or is rated by a nationally recognized reference as Xnot ratedY or Xnot availableY; 2) is available for purchase by all pharmacies and pharmacists in the state from national or regional pharmaceutical wholesalers operating in the state; and 3) has not been determined by the drug manufacturer to be obsolete. Further, the bill provides that any pharmacy benefit manager that uses a maximum allowable cost list must provide access to the maximum allowable cost list to each pharmacy or pharmacist subject to the maximum allowable cost list, update the maximum allowable cost list on a timely basis, provide a process for a pharmacy or pharmacist subject to the maximum allowable cost list to receive notification of an update to the maximum allowable cost list, and update the maximum allowable cost list no later than seven days after the pharmacy acquisition cost of the pharmaceutical product increases by 10 percent or more from at least 60 percent of the pharmaceutical wholesalers doing business in the state or there is a change in the methodology on which the maximum allowable cost list is based or in the value of a variable involved in the methodology. A maximum allowable cost list is a list of pharmaceutical products that sets forth the maximum amount that a pharmacy benefit manager will pay to a pharmacy or pharmacist for dispensing a pharmaceutical product. A maximum allowable cost list may directly establish maximum costs or may set forth a method for how the maximum costs are calculated. The bill further provides that a pharmacy benefit manager that uses a maximum allowable cost list must provide a process for a pharmacy or pharmacist to appeal and resolve disputes regarding claims that the maximum payment amount for a pharmaceutical product is below the pharmacy acquisition cost. A pharmacy benefit manager that receives an appeal from or on behalf of a pharmacy or pharmacist under this bill is required to resolve the appeal and notify the pharmacy or pharmacist of the pharmacy benefit manager[s determination no later than seven business days after the appeal is received. If the pharmacy benefit manager grants the relief requested in the appeal, the bill requires the pharmacy benefit manager to make the requested change in the maximum allowable cost, allow the pharmacy or pharmacist to reverse and rebill the relevant claim, provide to the pharmacy or pharmacist the national drug code number published in a directory by the federal Food and Drug Administration on which the increase or change is based, and make the change effective for each similarly situated pharmacy or pharmacist subject to the maximum allowable cost list. If the pharmacy benefit manager denies the relief requested in the appeal, the bill requires the pharmacy benefit manager to provide the pharmacy or pharmacist a reason for the denial, the national drug code number published in a directory by the FDA for the pharmaceutical product to which the claim relates, and the name of a national or regional wholesaler that has the pharmaceutical product currently in stock at a price below the amount specified in the pharmacy benefit manager[s maximum allowable cost list. The bill provides that a pharmacy benefit manager may not deny a pharmacy[s or pharmacist[s appeal if the relief requested in the appeal relates to the maximum allowable cost for a pharmaceutical product that is not available for the pharmacy or pharmacist to purchase at a cost that is below the pharmacy acquisition cost from the pharmaceutical wholesaler from which the pharmacy or pharmacist purchases the majority of pharmaceutical products for resale. If a pharmaceutical product is not available for a pharmacy or pharmacist to purchase at a cost that is below the pharmacy acquisition cost from the pharmaceutical wholesaler from which the pharmacy or pharmacist purchases the majority of pharmaceutical products for resale, the pharmacy benefit manager must revise the maximum allowable cost list to increase the maximum allowable cost for the pharmaceutical product to an amount equal to or greater than the pharmacy[s or pharmacist[s pharmacy acquisition cost and allow the pharmacy or pharmacist to reverse and rebill each claim affected by the pharmacy[s or pharmacist[s inability to procure the pharmaceutical product at a cost that is equal to or less than the maximum allowable cost that was the subject of the pharmacy[s or pharmacist[s appeal. The bill prohibits a pharmacy benefit manager from reimbursing a pharmacy or pharmacist in the state an amount less than the amount that the pharmacy benefit manager reimburses a pharmacy benefit manager affiliate for providing the same pharmaceutical product. Under the bill, a pharmacy benefit manager affiliate is a pharmacy or pharmacist that is an affiliate of a pharmacy benefit manager. Finally, the bill allows a pharmacy or pharmacist to decline to provide a pharmaceutical product to an individual or pharmacy benefit manager if, as a result of a maximum allowable cost list, the pharmacy or pharmacist would be paid less than the pharmacy acquisition cost of the pharmacy or pharmacist providing the pharmaceutical product. Drug formularies This bill makes several changes with respect to drug formularies. Under current law, a disability insurance policy that offers a prescription drug benefit, a self-insured health plan that offers a prescription drug benefit, or a pharmacy benefit manager acting on behalf of a disability insurance policy or self-insured health plan must provide to an enrollee advanced written notice of a formulary change that removes a prescription drug from the formulary of the policy or plan or that reassigns a prescription drug to a benefit tier for the policy or plan that has a higher deductible, copayment, or coinsurance. The advanced written notice of a formulary change must be provided no fewer than 30 days before the expected date of the removal or reassignment. This bill provides that a disability insurance policy or self-insured health plan that provides a prescription drug benefit shall make the formulary and all drug costs associated with the formulary available to plan sponsors and individuals prior to selection or enrollment. Further, the bill provides that no disability insurance policy, self-insured health plan, or pharmacy benefit manager acting on behalf of a disability insurance policy or self-insured health plan may remove a prescription drug from the formulary except at the time of coverage renewal. Finally, the bill provides that advanced written notice of a formulary change must be provided no fewer than 90 days before the expected date of the removal or reassignment of a prescription drug on the formulary. Pharmacy networks Under the bill, if an enrollee utilizes a pharmacy or pharmacist in a preferred network of pharmacies or pharmacists, no disability insurance policy or self- insured health plan that provides a prescription drug benefit or pharmacy benefit manager that provides services under a contract with a policy or plan may require the enrollee to pay any amount or impose on the enrollee any condition that would not be required if the enrollee utilized a different pharmacy or pharmacist in the same preferred network. Further, the bill provides that any disability insurance policy or self-insured health plan that provides a prescription drug benefit, or any pharmacy benefit manager that provides services under a contract with a policy or plan, that has established a preferred network of pharmacies or pharmacists must reimburse each pharmacy or pharmacist in the same network at the same rates. Audits of pharmacists and pharmacies This bill makes several changes to audits of pharmacists and pharmacies. The bill requires an entity that conducts audits of pharmacists and pharmacies to ensure that each pharmacist or pharmacy audited by the entity is audited under the same standards and parameters as other similarly situated pharmacists or pharmacies audited by the entity, that the entity randomizes the prescriptions that the entity audits and the entity audits the same number of prescriptions in each prescription benefit tier, and that each audit of a prescription reimbursed under Part D of the federal Medicare program is conducted separately from audits of prescriptions reimbursed under other policies or plans. The bill prohibits any pharmacy benefit manager from recouping reimbursements made to a pharmacist or pharmacy for errors that involve no actual financial harm to an enrollee or a policy or plan sponsor unless the error is the result of the pharmacist or pharmacy failing to comply with a formal corrective action plan. The bill further prohibits any pharmacy benefit manager from using extrapolation in calculating reimbursements that it may recoup, and instead requires a pharmacy benefit manager to base the finding of errors for which reimbursements will be recouped on an actual error in reimbursement and not a projection of the number of patients served having a similar diagnosis or on a projection of the number of similar orders or refills for similar prescription drugs. The bill provides that a pharmacy benefit manager that recoups any reimbursements made to a pharmacist or pharmacy for an error that was the cause of financial harm must return the recouped reimbursement to the enrollee or the policy or plan sponsor who was harmed by the error. Pharmacy benefit manager fiduciary and disclosure requirements The bill provides that a pharmacy benefit manager owes a fiduciary duty to a health benefit plan sponsor. The bill also requires that a pharmacy benefit manager annually disclose all of the following information to the health benefit plan sponsor: 1. The indirect profit received by the pharmacy benefit manager from owning a pharmacy or health service provider. 2. Any payments made to a consultant or broker who works on behalf of the plan sponsor. 3. From the amounts received from drug manufacturers, the amounts retained by the pharmacy benefit manager that are related to the plan sponsor[s claims or bona fide service fees. 4. The amounts received from network pharmacies and pharmacists and the amount retained by the pharmacy benefit manager. Discriminatory reimbursement of 340B entities The bill prohibits a pharmacy benefit manager from taking certain actions with respect to 340B covered entities, pharmacies and pharmacists contracted with 340B covered entities, and patients who obtain prescription drugs from 340B covered entities. The 340B drug pricing program is a federal program that requires pharmaceutical manufacturers that participate in the federal Medicaid program to sell outpatient drugs at discounted prices to certain health care organizations that provide health care for uninsured and low-income patients. Entities that are eligible for discounted prices under the 340B drug pricing program include federally qualified health centers, critical access hospitals, and certain public and nonprofit disproportionate share hospitals. The bill prohibits pharmacy benefit managers from doing any of the following: 1. Refusing to reimburse a 340B covered entity or a pharmacy or pharmacist contracted with a 340B covered entity for dispensing 340B drugs. 2. Imposing requirements or restrictions on 340B covered entities or pharmacies or pharmacists contracted with 340B covered entities that are not imposed on other entities, pharmacies, or pharmacists. 3. Reimbursing a 340B covered entity or a pharmacy or pharmacist contracted with a 340B covered entity for a 340B drug at a rate lower than the amount paid for the same drug to pharmacies or pharmacists that are not 340B covered entities or pharmacies or pharmacists contracted with a 340B covered entity. 4. Assessing a fee, charge back, or other adjustment against a 340B covered entity or a pharmacy or pharmacist contracted with a 340B covered entity after a claim has been paid or adjudicated. 5. Restricting the access of a 340B covered entity or a pharmacy or pharmacist contracted with a 340B covered entity to a third-party payer[s pharmacy network solely because the 340B covered entity or the pharmacy or pharmacist contracted with a 340B covered entity participates in the 340B drug pricing program. 6. Requiring a 340B covered entity or a pharmacy or pharmacist contracted with a 340B covered entity to contract with a specific pharmacy or pharmacist or health benefit plan in order to access a third-party payer[s pharmacy network. 7. Imposing a restriction or an additional charge on a patient who obtains a 340B drug from a 340B covered entity or a pharmacy or pharmacist contracted with a 340B covered entity. 8. Restricting the methods by which a 340B covered entity or a pharmacy or pharmacist contracted with a 340B covered entity may dispense or deliver 340B drugs. 9. Requiring a 340B covered entity or a pharmacy or pharmacist contracted with a 340B covered entity to share pharmacy bills or invoices with a pharmacy benefit manager, a third-party payer, or a health benefit plan. Application of prescription drug payments Health insurance policies and plans often apply cost-sharing requirements and out-of-pocket maximum amounts to the benefits covered by the policy or plan. A cost-sharing requirement is a share of covered benefits that an insured is required to pay under a health insurance policy or plan. Cost-sharing requirements include copayments, deductibles, and coinsurance. An out-of-pocket maximum amount is a limit specified by a policy or plan on the amount that an insured pays, and, once that limit is reached, the policy or plan covers the benefit entirely. The bill generally requires health insurance policies that offer prescription drug benefits, self-insured health plans, and pharmacy benefit managers acting on behalf of policies or plans to apply amounts paid by or on behalf of an individual covered under the policy or plan for brand name prescription drugs to any cost- sharing requirement or to any calculation of an out-of-pocket maximum amount of the policy or plan. Health insurance policies are referred to in the bill as disability insurance policies. Prohibited retaliation The bill prohibits a pharmacy benefit manager from retaliating against a pharmacy or pharmacist for reporting an alleged violation of certain laws applicable to pharmacy benefit managers or for exercising certain rights or remedies. Retaliation includes terminating or refusing to renew a contract with a pharmacy or pharmacist, subjecting a pharmacy or pharmacist to increased audits, or failing to promptly pay a pharmacy or pharmacist any money that the pharmacy benefit manager owes to the pharmacy or pharmacist. The bill provides that a pharmacy or pharmacist may bring an action in court for injunctive relief if a pharmacy benefit manager is retaliating against the pharmacy or pharmacist as provided in the bill. In addition to equitable relief, the court may award a pharmacy or pharmacist that prevails in such an action reasonable attorney fees and costs. For further information see the state fiscal estimate, which will be printed as an appendix to this bill. | In Committee |
| AB213 | Prohibiting hedge funds from acquiring single-family homes in this state. (FE) | This bill prohibits a hedge fund from acquiring a single-family home in this state. The bill provides that an ownership interest in a single-family home acquired or owned by a hedge fund in violation of the bill is forfeited to the state and that the attorney general is responsible for enforcement. For further information see the state fiscal estimate, which will be printed as an appendix to this bill. | In Committee |
| SB301 | Rehired annuitants. (FE) | Under current law, if a Wisconsin Retirement System annuitant, or a disability annuitant who has attained his or her normal retirement date, is appointed to a position with a WRS-participating employer or provides employee services to a WRS-participating employer in which he or she is expected to work at least two-thirds of what is considered full-time employment by the Department of Employee Trust Funds, the annuity must be suspended and no annuity payment is payable until after the participant again terminates covered employment. This bill removes the requirement that an annuitant who returns to work for a participating employer have his or her annuity suspended and become a participating employee and instead allows an annuitant who returns to work to either 1) elect to suspend his or her annuity and become a participating employee; or 2) elect to continue receiving his or her annuity and not become a participating employee. Under current law, a WRS participant who has applied to receive a retirement LRB-1617/1 MIM:cjs 2025 - 2026 Legislature SENATE BILL 301 annuity must wait at least 75 days between terminating covered employment with a WRS employer and returning to covered employment again as a participating employee. The bill reduces that period to 30 days. Because this bill relates to public employee retirement or pensions, it may be referred to the Joint Survey Committee on Retirement Systems for a report to be printed as an appendix to the bill. For further information see the state fiscal estimate, which will be printed as an appendix to this bill. | In Committee |
| SJR67 | Honoring Anna Mae Robertson for her extraordinary achievements and service to our nation. | Relating to: honoring Anna Mae Robertson for her extraordinary achievements and service to our nation. | In Committee |
| SB322 | A Department of Children and Families program to make payments to child care programs, granting rule-making authority, and making an appropriation. (FE) | This bill authorizes the Department of Children and Families to establish a program for making monthly payments and monthly per-child payments to certified child care providers, licensed child care centers, and child care programs established or contracted for by a school board. This new payment program is in addition to the current law system for providing child care payments under Wisconsin Shares. The bill requires DCF to promulgate rules to implement the program, including establishing eligibility requirements and payment amounts and setting requirements for how recipients may use the payments, and authorizes DCF to promulgate these rules as emergency rules. The bill funds the program through a new appropriation and by allocating federal moneys, including child care development funds and moneys received under the Temporary Assistance for Needy Families block grant program. LRB-3324/1 EHS:skw 2025 - 2026 Legislature SENATE BILL 322 The bill eliminates the current law method by which DCF may modify maximum payment rates for child care providers under Wisconsin Shares based on a child care provider[s rating under the quality rating system known as YoungStar. Wisconsin Shares is a part of the Wisconsin Works program under current law, which DCF administers and which provides work experience and benefits for low-income custodial parents who are at least 18 years old. Under current law, an individual who is the parent of a child under the age of 13 or, if the child is disabled, under the age of 19, who needs child care services to participate in various education or work activities, and who satisfies other eligibility criteria may receive a child care subsidy for child care services under Wisconsin Shares. For further information see the state fiscal estimate, which will be printed as an appendix to this bill. | In Committee |
| SB320 | Grants for LGBTQIA+ rights training for school counselors and school social workers and making an appropriation. (FE) | Under this bill, the Department of Public Instruction must award grants to school boards to provide training in LGBTQIA+ rights, in a program developed or approved by DPI, to school counselors and school social workers employed by school boards. The bill defines XLGBTQIA+Y as lesbian, gay, bisexual, transgender, queer, intersex, or any other nonheterosexual or noncisgender orientation, identity, or expression. For further information see the state and local fiscal estimate, which will be printed as an appendix to this bill. | In Committee |
| SB324 | Prohibiting conversion therapy. | This bill prohibits certain mental health providers from engaging in conversion therapy with a minor. Conversion therapy is defined under the bill to mean any intervention or method that has the purpose of attempting to change a person[s sexual orientation or gender identity, including any intervention or method that attempts to change behaviors or expressions of self or to reduce sexual or romantic attractions or feelings toward individuals of the same gender. However, under the bill, conversion therapy does not include counseling that assists an individual who is seeking to undergo a gender transition or who is in the process of undergoing a gender transition; counseling that provides a client with acceptance, support, or understanding; counseling that facilitates a client[s coping, social support, and identity exploration or development; or counseling in the form of sexual orientation-neutral or gender identity-neutral interventions provided for the purpose of preventing or addressing unlawful conduct or unsafe sexual practices, but only if the counseling is not provided for the purpose of attempting to change the client[s sexual orientation or gender identity. Under the bill, the Medical Examining Board, the Psychology Examining Board, and the Marriage and Family Therapy, Professional Counseling, and Social Work Examining Board are required to investigate any allegation that any person LRB-3040/1 JPC:skw 2025 - 2026 Legislature SENATE BILL 324 licensed, certified, or otherwise authorized to practice by the respective boards has violated the prohibition on performing conversion therapy. Upon a finding that the holder of a license, certificate, or other authorization has violated the prohibition on performing conversion therapy, the bill requires the applicable examining board to limit, suspend, or revoke the person[s license, certificate, or other authorization, or any combination of the three. | In Committee |
| SJR68 | Eliminating constitutional restrictions on marriage (first consideration). | relating to: eliminating constitutional restrictions on marriage (first consideration). | In Committee |
| SB203 | Regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE) | This bill makes several changes to the regulation of pharmacy benefit LRB-1278/1 JPC:cjs&skw 2025 - 2026 Legislature SENATE BILL 203 managers and their interactions with pharmacies and pharmacists. Under current law, pharmacy benefit managers are generally required to be licensed as a pharmacy benefit manager or an employee benefit plan administrator by the commissioner of insurance. A pharmacy benefit manager is an entity that contracts to administer or manage prescription drug benefits on behalf of an insurer, a cooperative, or another entity that provides prescription drug benefits to Wisconsin residents. Major provisions of the bill are summarized below. Pharmacy benefit manager regulation The bill requires a pharmacy benefit manager to pay a pharmacy or pharmacist a professional dispensing fee at a rate not less than is paid by the state under the Medical Assistance program for each pharmaceutical product that the pharmacy or pharmacist dispenses to an individual. The professional dispensing fee is required to be paid in addition to the amount the pharmacy benefit manager reimburses the pharmacy or pharmacist for the cost of the pharmaceutical product that the pharmacy or pharmacist dispenses. The Medical Assistance program is a joint state and federal program that provides health services to individuals who have limited financial resources. The bill prohibits a pharmacy benefit manager from assessing, charging, or collecting from a pharmacy or pharmacist any form of remuneration that passes from the pharmacy or pharmacist to the pharmacy benefit manager including claim-processing fees, performance-based fees, network-participation fees, or accreditation fees. Further, under the bill, a pharmacy benefit manager may not use any certification or accreditation requirement as a determinant of pharmacy network participation that is inconsistent with, more stringent than, or in addition to the federal requirements for licensure as a pharmacy and the requirements for licensure as a pharmacy provided under state law. The bill requires a pharmacy benefit manager to allow a participant or beneficiary of a pharmacy benefits plan or program that the pharmacy benefit manager serves to use any pharmacy or pharmacist in this state that is licensed to dispense the pharmaceutical product that the participant or beneficiary seeks to obtain if the pharmacy or pharmacist accepts the same terms and conditions that the pharmacy benefit manager establishes for at least one of the networks of pharmacies or pharmacists that the pharmacy benefit manager has established to serve individuals in the state. A pharmacy benefit manager may establish a preferred network of pharmacies or pharmacists and a nonpreferred network of pharmacies or pharmacists; however, under the bill, a pharmacy benefit manager may not prohibit a pharmacy or pharmacist from participating in either type of network provided that the pharmacy or pharmacist is licensed by this state and the federal government and accepts the same terms and conditions that the pharmacy benefit manager establishes for other pharmacies or pharmacists participating in the network that the pharmacy or pharmacist wants to join. Under the bill, a pharmacy benefit manager may not charge a participant or beneficiary of a LRB-1278/1 JPC:cjs&skw 2025 - 2026 Legislature SENATE BILL 203 pharmacy benefits plan or program that the pharmacy benefit manager serves a different copayment obligation or additional fee, or provide any inducement or financial incentive, for the participant or beneficiary to use a pharmacy or pharmacist in a particular network of pharmacies or pharmacists that the pharmacy benefit manager has established to serve individuals in the state. Further, the bill prohibits a pharmacy benefit manager, third-party payer, or health benefit plan from excluding a pharmacy or pharmacist from its network because the pharmacy or pharmacist serves less than a certain portion of the population of the state or serves a population living with certain health conditions. The bill provides that a pharmacy benefit manager may neither prohibit a pharmacy or pharmacist that dispenses a pharmaceutical product from, nor penalize a pharmacy or pharmacist that dispenses a pharmaceutical product for, informing an individual about the cost of the pharmaceutical product, the amount in reimbursement that the pharmacy or pharmacist receives for dispensing the pharmaceutical product, or any difference between the cost to the individual under the individual[s pharmacy benefits plan or program and the cost to the individual if the individual purchases the pharmaceutical product without making a claim for benefits under the individual[s pharmacy benefits plan or program. The bill prohibits any pharmacy benefit manager or any insurer or self- insured health plan from requiring, or penalizing a person who is covered under a health insurance policy or plan for using or for not using, a specific retail, mail- order, or other pharmacy provider within the network of pharmacy providers under the policy or plan. Prohibited penalties include an increase in premium, deductible, copayment, or coinsurance. The bill requires pharmacy benefit managers to remit payment for a claim to a pharmacy or pharmacist within 30 days from the day that the claim is submitted to the pharmacy benefit manager by the pharmacy or pharmacist. Pharmaceutical product reimbursements The bill provides that a pharmacy benefit manager that uses a maximum allowable cost list must include all of the following information on the list: 1) the average acquisition cost of each pharmaceutical product and the cost of the pharmaceutical product set forth in the national average drug acquisition cost data published by the federal centers for medicare and medicaid services; 2) the average manufacturer price of each pharmaceutical product; 3) the average wholesale price of each pharmaceutical product; 4) the brand effective rate or generic effective rate for each pharmaceutical product; 5) any applicable discount indexing; 6) the federal upper limit for each pharmaceutical product published by the federal centers for medicare and medicaid services; pharmaceutical product; and 8) any other terms that are used to establish the maximum allowable costs. The bill provides that a pharmacy benefit manager may place or continue a particular pharmaceutical product on a maximum allowable cost list only if the pharmaceutical product 1) is listed as a drug product equivalent or is rated by a LRB-1278/1 JPC:cjs&skw 7) the wholesale acquisition cost of each 2025 - 2026 Legislature SENATE BILL 203 nationally recognized reference as Xnot ratedY or Xnot availableY; 2) is available for purchase by all pharmacies and pharmacists in the state from national or regional pharmaceutical wholesalers operating in the state; and 3) has not been determined by the drug manufacturer to be obsolete. Further, the bill provides that any pharmacy benefit manager that uses a maximum allowable cost list must provide access to the maximum allowable cost list to each pharmacy or pharmacist subject to the maximum allowable cost list, update the maximum allowable cost list on a timely basis, provide a process for a pharmacy or pharmacist subject to the maximum allowable cost list to receive notification of an update to the maximum allowable cost list, and update the maximum allowable cost list no later than seven days after the pharmacy acquisition cost of the pharmaceutical product increases by 10 percent or more from at least 60 percent of the pharmaceutical wholesalers doing business in the state or there is a change in the methodology on which the maximum allowable cost list is based or in the value of a variable involved in the methodology. A maximum allowable cost list is a list of pharmaceutical products that sets forth the maximum amount that a pharmacy benefit manager will pay to a pharmacy or pharmacist for dispensing a pharmaceutical product. A maximum allowable cost list may directly establish maximum costs or may set forth a method for how the maximum costs are calculated. The bill further provides that a pharmacy benefit manager that uses a maximum allowable cost list must provide a process for a pharmacy or pharmacist to appeal and resolve disputes regarding claims that the maximum payment amount for a pharmaceutical product is below the pharmacy acquisition cost. A pharmacy benefit manager that receives an appeal from or on behalf of a pharmacy or pharmacist under this bill is required to resolve the appeal and notify the pharmacy or pharmacist of the pharmacy benefit manager[s determination no later than seven business days after the appeal is received. If the pharmacy benefit manager grants the relief requested in the appeal, the bill requires the pharmacy benefit manager to make the requested change in the maximum allowable cost, allow the pharmacy or pharmacist to reverse and rebill the relevant claim, provide to the pharmacy or pharmacist the national drug code number published in a directory by the federal Food and Drug Administration on which the increase or change is based, and make the change effective for each similarly situated pharmacy or pharmacist subject to the maximum allowable cost list. If the pharmacy benefit manager denies the relief requested in the appeal, the bill requires the pharmacy benefit manager to provide the pharmacy or pharmacist a reason for the denial, the national drug code number published in a directory by the FDA for the pharmaceutical product to which the claim relates, and the name of a national or regional wholesaler that has the pharmaceutical product currently in stock at a price below the amount specified in the pharmacy benefit manager[s maximum allowable cost list. The bill provides that a pharmacy benefit manager may not deny a pharmacy[s or pharmacist[s appeal if the relief requested in the appeal relates to LRB-1278/1 JPC:cjs&skw 2025 - 2026 Legislature SENATE BILL 203 the maximum allowable cost for a pharmaceutical product that is not available for the pharmacy or pharmacist to purchase at a cost that is below the pharmacy acquisition cost from the pharmaceutical wholesaler from which the pharmacy or pharmacist purchases the majority of pharmaceutical products for resale. If a pharmaceutical product is not available for a pharmacy or pharmacist to purchase at a cost that is below the pharmacy acquisition cost from the pharmaceutical wholesaler from which the pharmacy or pharmacist purchases the majority of pharmaceutical products for resale, the pharmacy benefit manager must revise the maximum allowable cost list to increase the maximum allowable cost for the pharmaceutical product to an amount equal to or greater than the pharmacy[s or pharmacist[s pharmacy acquisition cost and allow the pharmacy or pharmacist to reverse and rebill each claim affected by the pharmacy[s or pharmacist[s inability to procure the pharmaceutical product at a cost that is equal to or less than the maximum allowable cost that was the subject of the pharmacy[s or pharmacist[s appeal. The bill prohibits a pharmacy benefit manager from reimbursing a pharmacy or pharmacist in the state an amount less than the amount that the pharmacy benefit manager reimburses a pharmacy benefit manager affiliate for providing the same pharmaceutical product. Under the bill, a pharmacy benefit manager affiliate is a pharmacy or pharmacist that is an affiliate of a pharmacy benefit manager. Finally, the bill allows a pharmacy or pharmacist to decline to provide a pharmaceutical product to an individual or pharmacy benefit manager if, as a result of a maximum allowable cost list, the pharmacy or pharmacist would be paid less than the pharmacy acquisition cost of the pharmacy or pharmacist providing the pharmaceutical product. Drug formularies This bill makes several changes with respect to drug formularies. Under current law, a disability insurance policy that offers a prescription drug benefit, a self-insured health plan that offers a prescription drug benefit, or a pharmacy benefit manager acting on behalf of a disability insurance policy or self-insured health plan must provide to an enrollee advanced written notice of a formulary change that removes a prescription drug from the formulary of the policy or plan or that reassigns a prescription drug to a benefit tier for the policy or plan that has a higher deductible, copayment, or coinsurance. The advanced written notice of a formulary change must be provided no fewer than 30 days before the expected date of the removal or reassignment. This bill provides that a disability insurance policy or self-insured health plan that provides a prescription drug benefit shall make the formulary and all drug costs associated with the formulary available to plan sponsors and individuals prior to selection or enrollment. Further, the bill provides that no disability insurance policy, self-insured health plan, or pharmacy benefit manager acting on behalf of a disability insurance policy or self-insured health plan may remove a prescription LRB-1278/1 JPC:cjs&skw 2025 - 2026 Legislature SENATE BILL 203 drug from the formulary except at the time of coverage renewal. Finally, the bill provides that advanced written notice of a formulary change must be provided no fewer than 90 days before the expected date of the removal or reassignment of a prescription drug on the formulary. Pharmacy networks Under the bill, if an enrollee utilizes a pharmacy or pharmacist in a preferred network of pharmacies or pharmacists, no disability insurance policy or self- insured health plan that provides a prescription drug benefit or pharmacy benefit manager that provides services under a contract with a policy or plan may require the enrollee to pay any amount or impose on the enrollee any condition that would not be required if the enrollee utilized a different pharmacy or pharmacist in the same preferred network. Further, the bill provides that any disability insurance policy or self-insured health plan that provides a prescription drug benefit, or any pharmacy benefit manager that provides services under a contract with a policy or plan, that has established a preferred network of pharmacies or pharmacists must reimburse each pharmacy or pharmacist in the same network at the same rates. Audits of pharmacists and pharmacies This bill makes several changes to audits of pharmacists and pharmacies. The bill requires an entity that conducts audits of pharmacists and pharmacies to ensure that each pharmacist or pharmacy audited by the entity is audited under the same standards and parameters as other similarly situated pharmacists or pharmacies audited by the entity, that the entity randomizes the prescriptions that the entity audits and the entity audits the same number of prescriptions in each prescription benefit tier, and that each audit of a prescription reimbursed under Part D of the federal Medicare program is conducted separately from audits of prescriptions reimbursed under other policies or plans. The bill prohibits any pharmacy benefit manager from recouping reimbursements made to a pharmacist or pharmacy for errors that involve no actual financial harm to an enrollee or a policy or plan sponsor unless the error is the result of the pharmacist or pharmacy failing to comply with a formal corrective action plan. The bill further prohibits any pharmacy benefit manager from using extrapolation in calculating reimbursements that it may recoup, and instead requires a pharmacy benefit manager to base the finding of errors for which reimbursements will be recouped on an actual error in reimbursement and not a projection of the number of patients served having a similar diagnosis or on a projection of the number of similar orders or refills for similar prescription drugs. The bill provides that a pharmacy benefit manager that recoups any reimbursements made to a pharmacist or pharmacy for an error that was the cause of financial harm must return the recouped reimbursement to the enrollee or the policy or plan sponsor who was harmed by the error. Pharmacy benefit manager fiduciary and disclosure requirements The bill provides that a pharmacy benefit manager owes a fiduciary duty to a health benefit plan sponsor. The bill also requires that a pharmacy benefit LRB-1278/1 JPC:cjs&skw 2025 - 2026 Legislature SENATE BILL 203 manager annually disclose all of the following information to the health benefit plan sponsor: 1. The indirect profit received by the pharmacy benefit manager from owning a pharmacy or health service provider. 2. Any payments made to a consultant or broker who works on behalf of the plan sponsor. 3. From the amounts received from drug manufacturers, the amounts retained by the pharmacy benefit manager that are related to the plan sponsor[s claims or bona fide service fees. 4. The amounts received from network pharmacies and pharmacists and the amount retained by the pharmacy benefit manager. Discriminatory reimbursement of 340B entities The bill prohibits a pharmacy benefit manager from taking certain actions with respect to 340B covered entities, pharmacies and pharmacists contracted with 340B covered entities, and patients who obtain prescription drugs from 340B covered entities. The 340B drug pricing program is a federal program that requires pharmaceutical manufacturers that participate in the federal Medicaid program to sell outpatient drugs at discounted prices to certain health care organizations that provide health care for uninsured and low-income patients. Entities that are eligible for discounted prices under the 340B drug pricing program include federally qualified health centers, critical access hospitals, and certain public and nonprofit disproportionate share hospitals. The bill prohibits pharmacy benefit managers from doing any of the following: 1. Refusing to reimburse a 340B covered entity or a pharmacy or pharmacist contracted with a 340B covered entity for dispensing 340B drugs. 2. Imposing requirements or restrictions on 340B covered entities or pharmacies or pharmacists contracted with 340B covered entities that are not imposed on other entities, pharmacies, or pharmacists. 3. Reimbursing a 340B covered entity or a pharmacy or pharmacist contracted with a 340B covered entity for a 340B drug at a rate lower than the amount paid for the same drug to pharmacies or pharmacists that are not 340B covered entities or pharmacies or pharmacists contracted with a 340B covered entity. 4. Assessing a fee, charge back, or other adjustment against a 340B covered entity or a pharmacy or pharmacist contracted with a 340B covered entity after a claim has been paid or adjudicated. 5. Restricting the access of a 340B covered entity or a pharmacy or pharmacist contracted with a 340B covered entity to a third-party payer[s pharmacy network solely because the 340B covered entity or the pharmacy or pharmacist contracted with a 340B covered entity participates in the 340B drug pricing program. 6. Requiring a 340B covered entity or a pharmacy or pharmacist contracted LRB-1278/1 JPC:cjs&skw 2025 - 2026 Legislature SENATE BILL 203 with a 340B covered entity to contract with a specific pharmacy or pharmacist or health benefit plan in order to access a third-party payer[s pharmacy network. 7. Imposing a restriction or an additional charge on a patient who obtains a 340B drug from a 340B covered entity or a pharmacy or pharmacist contracted with a 340B covered entity. 8. Restricting the methods by which a 340B covered entity or a pharmacy or pharmacist contracted with a 340B covered entity may dispense or deliver 340B drugs. 9. Requiring a 340B covered entity or a pharmacy or pharmacist contracted with a 340B covered entity to share pharmacy bills or invoices with a pharmacy benefit manager, a third-party payer, or a health benefit plan. Application of prescription drug payments Health insurance policies and plans often apply cost-sharing requirements and out-of-pocket maximum amounts to the benefits covered by the policy or plan. A cost-sharing requirement is a share of covered benefits that an insured is required to pay under a health insurance policy or plan. Cost-sharing requirements include copayments, deductibles, and coinsurance. An out-of-pocket maximum amount is a limit specified by a policy or plan on the amount that an insured pays, and, once that limit is reached, the policy or plan covers the benefit entirely. The bill generally requires health insurance policies that offer prescription drug benefits, self-insured health plans, and pharmacy benefit managers acting on behalf of policies or plans to apply amounts paid by or on behalf of an individual covered under the policy or plan for brand name prescription drugs to any cost- sharing requirement or to any calculation of an out-of-pocket maximum amount of the policy or plan. Health insurance policies are referred to in the bill as disability insurance policies. Prohibited retaliation The bill prohibits a pharmacy benefit manager from retaliating against a pharmacy or pharmacist for reporting an alleged violation of certain laws applicable to pharmacy benefit managers or for exercising certain rights or remedies. Retaliation includes terminating or refusing to renew a contract with a pharmacy or pharmacist, subjecting a pharmacy or pharmacist to increased audits, or failing to promptly pay a pharmacy or pharmacist any money that the pharmacy benefit manager owes to the pharmacy or pharmacist. The bill provides that a pharmacy or pharmacist may bring an action in court for injunctive relief if a pharmacy benefit manager is retaliating against the pharmacy or pharmacist as provided in the bill. In addition to equitable relief, the court may award a pharmacy or pharmacist that prevails in such an action reasonable attorney fees and costs. For further information see the state fiscal estimate, which will be printed as an appendix to this bill. LRB-1278/1 JPC:cjs&skw 2025 - 2026 Legislature SENATE BILL 203 | In Committee |
| SB271 | Right to bodily autonomy, elimination of certain abortion-related regulations, and coverage of abortion under certain health care coverage plans. (FE) | This bill specifies that every individual has the fundamental right to bodily autonomy, which includes the right to access abortion. Under the bill, the state may not prohibit an individual from obtaining an abortion if an abortion is necessary in the professional judgment of the individual[s medical provider. Also under the bill, a law or rule of this state that restricts a individual[s access to abortion is unenforceable if the law or rule does not confer any legitimate health benefit. Any person that is or may be aggrieved by the enforcement of a law or rule passed or LRB-2921/1 SWB&JPC:cdc 2025 - 2026 Legislature SENATE BILL 271 promulgated after the effective date of the bill that would be unenforceable under the bill may bring an action in state or federal court for injunctive relief or damages against a state or local official who enforces or attempts to enforce such a law or rule. The bill also expressly provides that all requirements applicable to health care providers are applicable to providers of abortion care. The bill does not change standard informed consent requirements applicable to all medical procedures, including abortion, but removes additional requirements specific to the performance of an abortion that exceed those standard informed consent requirements. Current law requires that these additional requirements must be met in order for a woman upon whom an abortion is to be performed or induced to give voluntary and informed consent to an abortion. Except in a medical emergency, under current law, a woman[s consent to an abortion is considered informed only if, with certain exceptions, at least 24 hours before the abortion is performed or induced, the physician or an assistant has, in person, orally provided the woman with certain information and given to the woman certain written materials. The bill repeals these requirements. Under current law, the state is required to offer to all of its employees at least 2 insured or uninsured health care coverage plans. Further, under current law, certain employers including counties, villages, towns, school districts, and other governmental units or instrumentalities other than the state may offer to all of its employees a health care coverage plan through a program offered by the Group Insurance Board. Current law prohibits these plans from providing coverage for abortion or services the funding for which is ineligible under current law. The bill repeals these restrictions and instead requires coverage of abortion and any other medical services necessary to provide abortion under these health coverage plans if the health care coverage plan provides maternity coverage. The bill also repeals other various abortion-related laws, including all of the following: 1. The bill eliminates the prohibition on giving a woman an abortion-inducing drug unless the physician who provided the drug for the woman performs a physical exam on the woman and is physically present in the room when the drug is given to the woman. 2. The bill eliminates the prohibition on coverage of abortions by qualified health plans offered through an exchange in this state. 3. The bill eliminates the prohibition on performing abortions by a physician that does not have admitting privileges in a hospital within 30 miles of the location where the abortion is to be performed. This statute was previously held to be unenforceable by the U.S. Court of Appeals for the 7th Circuit in Planned Parenthood of Wis., Inc. v. Schimel, 806 F.3d 908 (7th Cir. 2015), which affirmed a permanent injunction granted by the U.S. District Court for the Western District of Wisconsin. 4. The bill repeals a statute that provides that any person, other than the mother, who intentionally destroys the life of an unborn child may be fined not more than $10,000, imprisoned for not more than six years, or both. XUnborn childY is defined in the statute as a human being from the time of conception until born alive. LRB-2921/1 SWB&JPC:cdc 2025 - 2026 Legislature SENATE BILL 271 The statute also provides that any person, other than the mother, who intentionally destroys the life of an unborn quick child or causes the mother[s death by an act done with intent to destroy the life of an unborn child may be fined not more than $50,000, imprisoned for not more than 15 years, or both. None of these penalties apply to a therapeutic abortion that is performed by a physician; is necessary, or advised by two other physicians as necessary, to save the life of the mother; and, unless an emergency prevents, is performed in a licensed maternity hospital. This statute was previously held to be unenforceable. It was cited in Roe v. Wade, 410 U.S. 113 (1973), as similar to a Texas statute that was held to violate the due process clause of the 14th Amendment to the U.S. Constitution. The unenforceability of the statute following the Roe v. Wade decision was noted in a subsequent decision by a federal district court, Larkin v. McCann, 368 F. Supp. 1352 (E.D. Wis. 1974). In June 2022, the U.S. Supreme Court overturned the Roe v. Wade decision in Dobbs v. Jackson Women[s Health Org., 142 S. Ct. 2228 (2022). Litigation concerning the status of the statute is currently pending in state court. In December 2023, the Dane County Circuit Court issued a decision and order declaring that the statute Xdoes not apply to abortions.Y Kaul v. Urmanski, No. 22- CV-1594, slip op. at 14 (Wis. Dane Cnty. Cir. Ct. Dec. 5, 2023). An appeal is pending before the Wisconsin Supreme Court. See Kaul v. Urmanski, No. 2023AP002362 (Wis. July 2, 2024) (order granting a petition to bypass the court of appeals). The Wisconsin Supreme Court has also granted a petition for leave to commence an original action regarding whether the state constitution protects a right to receive an abortion and a right for physicians to provide abortions. See Planned Parenthood of Wisconsin v. Urmanski, No. 2024AP000330 (Wis. July 2, 2024) (order granting leave to commence an original action); see Petition to Wis. S. Ct. to Take Jurisdiction of an Original Action, Planned Parenthood of Wisconsin v. Urmanski, No. 2024AP000330 (Wis. filed Feb. 22, 2024). The bill also repeals the criminal penalty on a person who is not a physician and who intentionally performs an abortion. The bill does not affect any other criminal prohibition or limitation on abortion in current law, such as the general prohibition on performing an abortion after the fetus or unborn child has reached viability, or any other homicide prohibition. The bill also does not affect a separate provision in current law that prohibits prosecution of and imposing or enforcing a fine or imprisonment against a woman who obtains an abortion or otherwise violates any abortion law with respect to her unborn child or fetus. For further information see the state and local fiscal estimate, which will be printed as an appendix to this bill. This proposal may contain a health insurance mandate requiring a social and financial impact report under s. 601.423, stats. | In Committee |
| AJR65 | Congratulating the Milwaukee Academy of Science Boys Basketball Team on their 2025 Division III State Basketball Championship. | Relating to: congratulating the Milwaukee Academy of Science Boys Basketball Team on their 2025 Division III State Basketball Championship. | In Committee |
| SB208 | Prohibiting hedge funds from acquiring single-family homes in this state. (FE) | This bill prohibits a hedge fund from acquiring a single-family home in this state. The bill provides that an ownership interest in a single-family home acquired or owned by a hedge fund in violation of the bill is forfeited to the state and that the attorney general is responsible for enforcement. For further information see the state fiscal estimate, which will be printed as an appendix to this bill. | In Committee |
| AB206 | The procedure for adding federal newborn screening recommendations to the state-required newborn screenings, granting rule-making authority, and providing an exemption from emergency rule procedures. (FE) | In general, under current law, newborns must be tested for certain congenital and metabolic disorders as specified in rules promulgated by the Department of Health Services. The federal Department of Health and Human Services maintains a list of disorders for which it recommends testing in newborns, known as the federal Recommended Uniform Screening Panel (RUSP). Under this bill, DHS must evaluate each disorder that is included in the RUSP as of January 1, 2025, to determine whether newborns in this state should be tested for that disorder. This requirement does not apply to any disorder in the RUSP if, as of January 1, 2025, the disorder is already included in the list of disorders for which newborns must be tested in this state. In addition, the bill requires DHS to evaluate any disorder added to the RUSP after January 1, 2025, to determine whether newborns in this state should be tested for that newly added disorder. If DHS determines newborns should not be tested for the disorder, DHS must annually review medical literature and the department[s capacity and resources to test for the disorder in order to determine whether to reevaluate the inclusion of the disorder in newborn testing in this state. If, in any of these evaluations or reevaluations, DHS determines that a disorder in the RUSP should be added to the list of disorders for which newborns must be tested in this state, the bill requires DHS to promulgate rules to add that disorder. The requirements for evaluations, reviews, and reevaluations under the bill do not apply to a disorder in the RUSP if DHS is in the process of adding, by rule, the disorder to the list of disorders for which newborns must be tested in this state. However, if the rule-making procedure for that disorder does not result in promulgation of a rule, then DHS must consider the disorder under the review and reevaluation procedures under the bill. For further information see the state fiscal estimate, which will be printed as an appendix to this bill. | In Committee |
| SJR60 | Proclaiming June 6, 2025, as Gun Violence Awareness Day in Wisconsin. | Relating to: proclaiming June 6, 2025, as Gun Violence Awareness Day in Wisconsin. | In Committee |
| AJR61 | Proclaiming June 6, 2025, as Gun Violence Awareness Day in Wisconsin. | Relating to: proclaiming June 6, 2025, as Gun Violence Awareness Day in Wisconsin. | In Committee |
| AB138 | Jailers and protective occupation annuitants in the Wisconsin Retirement System who are rehired by a participating employer. (FE) | Under current law, certain persons who receive a retirement or disability annuity from the Wisconsin Retirement System and who are hired by an employer that participates in the WRS must suspend that annuity and may not receive a WRS annuity payment until the employee is no longer in a WRS-covered position. This suspension applies to a person who 1) has reached his or her normal retirement date; 2) is appointed to a position with a WRS-participating employer or provides employee services to a WRS-participating employer; and 3) is expected to work at least two-thirds of what is considered full-time employment by the Department of Employee Trust Funds. This bill creates an exception to this suspension for an annuitant who retired from employment with a participating employer and who is subsequently rehired or provides employee services after retirement if 1) at the time the annuitant initially retires from covered employment with a participating employer, the annuitant does not have an agreement with any participating employer to return to employment; 2) the annuitant elects to not become a participating employee at the time the annuitant is rehired or enters into a contract after retirement; and 3) either the annuitant retired as a protective occupation participant or the annuitant retired as a county jailer who was not a protective occupation participant under the WRS. Under current law, a county jailer has the opportunity to opt out of becoming a protective occupation participant under the WRS. The bill treats county jailers who opt out of becoming a protective occupation participant in the same manner as county jailers who are protective occupation participants. Because this bill relates to public employee retirement or pensions, it may be referred to the Joint Survey Committee on Retirement Systems for a report to be printed as an appendix to the bill. For further information see the local fiscal estimate, which will be printed as an appendix to this bill. | In Committee |
| SB74 | Ratification of the Social Work Licensure Compact. (FE) | This bill ratifies and enters Wisconsin into the Social Work Licensure Compact, which provides for the ability of a social worker to become eligible to LRB-1310/1 MED:emw 2025 - 2026 Legislature SENATE BILL 74 practice in other compact states. Significant provisions of the compact include the following: 1. The creation of a Social Work Licensure Compact Commission, which includes one member or administrator of the licensure authorities of each member state. The commission has various powers and duties granted in the compact, including establishing bylaws, promulgating binding rules for the compact, hiring officers, electing or appointing employees, and establishing and electing an executive committee. The commission may levy on and collect an annual assessment from each member state or impose fees on licensees of member states to cover the cost of the operations and activities of the commission and its staff. 2. The ability for a social worker who is licensed in a home state and satisfies certain other criteria to obtain a multistate license, which allows a social worker to practice social work in all other compact states (remote states) under a multistate authorization to practice. The compact specifies a number of requirements in order for an individual to obtain a social worker multistate license, including holding or being eligible for a social worker license in a home state, paying any required fees, and satisfying a number of criteria that are specific to the category of social work license the individual is seeking—bachelor[s, master[s, or clinical. A regulated social worker[s services in a remote state are subject to that member state[s regulatory authority. A remote state may take actions against a social worker[s multistate authorization to practice within that remote state, and if any adverse action is taken by a home state against a licensee[s multistate license, the social worker[s multistate authorization to practice in all other member states is deactivated until all encumbrances have been removed from the multistate license. 3. The ability of member states to issue subpoenas that are enforceable in other states. 4. The creation of a coordinated data system containing licensure and disciplinary action information on social workers. The compact requires all home state disciplinary orders that impose adverse actions against the license of a regulated social worker to include a statement that the regulated social worker[s multistate authorization to practice is deactivated in all member states until all conditions of the decision, order, or agreement are satisfied. A member state must submit a uniform data set to the data system on all individuals to whom the compact is applicable as required by the rules of the commission. 5. Provisions regarding resolutions of disputes among member states and between member and nonmember states, including a process for termination of a state[s membership in the compact if the state defaults on its obligations under the compact. Since the compact has already been enacted by the minimum number of states required for it to become active, the compact becomes effective in this state upon enactment of the bill. The compact provides that it may be amended upon enactment of an amendment by all member states. A state may withdraw from the compact by repealing the statute authorizing the compact, but the compact provides LRB-1310/1 MED:emw 2025 - 2026 Legislature SENATE BILL 74 that a withdrawal does not take effect until 180 days after the effective date of that repeal. For further information see the state fiscal estimate, which will be printed as an appendix to this bill. | In Committee |
| SB254 | Funding for the War Memorial Center and making an appropriation. (FE) | Under current law, by agreement between the county board and any nonprofit private corporation, a county having a population of 750,000 or more may establish and maintain a memorial to commemorate the lives and deeds of persons who served the state or nation in war or other national service. Milwaukee County is the only county in the state with a population of 750,000 or more, and the county established and maintains a memorial called the War Memorial Center. This bill creates a continuing appropriation account for the Department of Veterans Affairs from which the War Memorial Center[s memorial board may request DVA to provide funds to it for support of the memorial. In making a request for the funds, the memorial board is required to describe its intended use of the funds, and to aver that it has secured equal matching funds that it will contribute to its intended project supporting the War Memorial Center. In addition, in each fiscal year in which the War Memorial Center[s memorial board receives funds from DVA as described under the bill, the War Memorial Center[s memorial board is required to submit a report to the Joint Committee on Finance that describes how the funds were used and that indicates how much money remains in the appropriation account. LRB-2889/1 JAM:skw 2025 - 2026 Legislature SENATE BILL 254 For further information see the state and local fiscal estimate, which will be printed as an appendix to this bill. | In Committee |
| AB246 | Cost-sharing caps on prescription drugs and medical supplies to treat asthma under health insurance policies and plans. (FE) | This bill requires health insurance policies and plans that provide coverage of prescription drugs to cover prescription drugs and related medical supplies for the treatment of asthma. This bill provides that Xrelated medical suppliesY includes asthma inhalers and other medical supply items necessary to effectively and appropriately administer a prescription drug prescribed to treat asthma. This bill requires policies and plans to limit the amount of any enrollee cost-sharing for the coverage provided in the bill to no more than $25 per one-month supply for each prescription drug prescribed to treat asthma and to no more than $50 per month for all related medical supplies. Cost-sharing may not increase with the number of conditions for which an enrollee is treated. Further, the coverage provided in the bill may not be subject to any deductible. However, the bill provides that the limitations on cost-sharing and deductibles do not apply to the extent that the limitations would result in ineligibility for a health savings account under the federal Internal Revenue Code. This proposal may contain a health insurance mandate requiring a social and financial impact report under s. 601.423, stats. For further information see the state fiscal estimate, which will be printed as an appendix to this bill. | In Committee |
| SB251 | Cost-sharing caps on prescription drugs and medical supplies to treat asthma under health insurance policies and plans. (FE) | This bill requires health insurance policies and plans that provide coverage of prescription drugs to cover prescription drugs and related medical supplies for the treatment of asthma. This bill provides that Xrelated medical suppliesY includes asthma inhalers and other medical supply items necessary to effectively and appropriately administer a prescription drug prescribed to treat asthma. This bill requires policies and plans to limit the amount of any enrollee cost-sharing for the coverage provided in the bill to no more than $25 per one-month supply for each prescription drug prescribed to treat asthma and to no more than $50 per month for all related medical supplies. Cost-sharing may not increase with the number of conditions for which an enrollee is treated. Further, the coverage provided in the bill may not be subject to any deductible. However, the bill provides that the limitations on cost-sharing and deductibles do not apply to the extent that the limitations would result in ineligibility for a health savings account under the federal Internal Revenue Code. This proposal may contain a health insurance mandate requiring a social and financial impact report under s. 601.423, stats. LRB-2917/1 JPC:cjs&skw 2025 - 2026 Legislature SENATE BILL 251 For further information see the state fiscal estimate, which will be printed as an appendix to this bill. | In Committee |
| SB73 | Prosecuting or adjudicating delinquent a person under the age of 18 for committing an act of prostitution. | Under current law, a person who is under the age of 18 may be prosecuted or adjudicated delinquent for committing an act of prostitution, a Class A misdemeanor. Under this bill, a person who is under the age of 18 may not be prosecuted or adjudicated delinquent for committing an act of prostitution. This bill also eliminates the option under current law in cases where a person under the age of 18 has committed an act of prostitution for a court to enter a consent decree under the Juvenile Justice Code, or a deferred prosecution agreement under the Juvenile Justice Code or adult criminal statutes, if the court determines that a consent decree or deferred prosecution agreement will serve the best interests of the person being prosecuted and will not harm society. | In Committee |
| AJR12 | Honoring the life and public service of Assembly Chief Clerk Patrick Fuller. | Relating to: honoring the life and public service of Assembly Chief Clerk Patrick Fuller. | Signed/Enacted/Adopted |
| AJR18 | Honoring the life and public service of Representative Jonathan Brostoff. | Relating to: honoring the life and public service of Representative Jonathan Brostoff. | Signed/Enacted/Adopted |
| SJR56 | Proclaiming April 20 to 26 as 2025 National Infertility Awareness Week in Wisconsin. | Relating to: proclaiming April 20 to 26 as 2025 National Infertility Awareness Week in Wisconsin. | In Committee |
| AJR46 | Congratulating the Wauwatosa East Girls Basketball Team on their 2025 Division II State Basketball Championship. | Relating to: congratulating the Wauwatosa East Girls Basketball Team on their 2025 Division II State Basketball Championship. | Signed/Enacted/Adopted |
| AJR45 | Congratulating the Wauwatosa West Boys Basketball Team on their 2025 Division II State Basketball Championship. | Relating to: congratulating the Wauwatosa West Boys Basketball Team on their 2025 Division II State Basketball Championship. | Signed/Enacted/Adopted |
| SJR43 | Congratulating the Wauwatosa West Boys Basketball Team on their 2025 Division II State Basketball Championship. | Relating to: congratulating the Wauwatosa West Boys Basketball Team on their 2025 Division II State Basketball Championship. | In Committee |
| SJR44 | Congratulating the Wauwatosa East Girls Basketball Team on their 2025 Division II State Basketball Championship. | Relating to: congratulating the Wauwatosa East Girls Basketball Team on their 2025 Division II State Basketball Championship. | In Committee |
| AJR39 | Recognizing Asian American and Native Hawaiian/Pacific Islander (AANHPI) Heritage Month as a time to honor the important contributions of Asians, Asian Americans, Native Hawaiians, and Pacific Islanders to the history of the United States. | Relating to: recognizing Asian American and Native Hawaiian/Pacific Islander (AANHPI) Heritage Month as a time to honor the important contributions of Asians, Asian Americans, Native Hawaiians, and Pacific Islanders to the history of the United States. | Crossed Over |
| AJR41 | Proclaiming May 2025 and May 2026 as Jewish American Heritage Months. | Relating to: proclaiming May 2025 and May 2026 as Jewish American Heritage Months. | Crossed Over |
| AJR40 | Celebrating 50 years of strength and resilience of the Hmong, Lao, Cambodian, and Vietnamese people. | Relating to: celebrating 50 years of strength and resilience of the Hmong, Lao, Cambodian, and Vietnamese people. | Crossed Over |
| AJR49 | Congratulating the Milwaukee Rufus King Cheer and Stunt Team on their double state championship win in 2025. | Relating to: congratulating the Milwaukee Rufus King Cheer and Stunt Team on their double state championship win in 2025. | Crossed Over |
| SB14 | Pelvic exams on unconscious patients and creating an administrative rule related to hospital requirements for pelvic exams on unconscious patients. | This bill requires hospitals to ensure written informed consent is obtained from a patient before a pelvic exam is performed solely for educational purposes on the patient while the patient is under general anesthesia or otherwise unconscious. The bill also creates a Department of Health Services rule providing that hospitals must maintain written policies and procedures requiring written informed consent to be obtained from a patient before a pelvic exam is performed solely for educational purposes on the patient while the patient is under general anesthesia or otherwise unconscious. | Passed |
| AB11 | Pelvic exams on unconscious patients and creating an administrative rule related to hospital requirements for pelvic exams on unconscious patients. | This bill requires hospitals to ensure written informed consent is obtained from a patient before a pelvic exam is performed solely for educational purposes on the patient while the patient is under general anesthesia or otherwise unconscious. The bill also creates a Department of Health Services rule providing that hospitals must maintain written policies and procedures requiring written informed consent to be obtained from a patient before a pelvic exam is performed solely for educational purposes on the patient while the patient is under general anesthesia or otherwise unconscious. | In Committee |
| SJR45 | Proclaiming May 2025 and May 2026 as Jewish American Heritage Months. | Relating to: proclaiming May 2025 and May 2026 as Jewish American Heritage Months. | In Committee |
| SJR33 | Declaration of the Economic Justice Bill of Rights. | Relating to: declaration of the Economic Justice Bill of Rights. | In Committee |
| AJR33 | Declaration of the Economic Justice Bill of Rights. | Relating to: declaration of the Economic Justice Bill of Rights. | In Committee |
| SJR42 | Proclaiming 2025 as the year of the snake. | Relating to: proclaiming 2025 as the year of the snake. | In Committee |
| AB186 | Study of guaranteed employment grant program and making an appropriation. (FE) | This bill requires the Department of Workforce Development to study the creation of a job guarantee and full employment grant program. Under the program, DWD and municipalities provide grants to public and nonprofit employers in the care economy to provide certain job opportunities in positions covered by a collective bargaining unit to individuals with disabilities, heads of households with incomes that are 150 percent or less than the federal poverty line, individuals who have been unemployed for extended periods, individuals who were previously incarcerated, and individuals between 18 and 24 years old. The bill requires DWD to submit a report with the findings and recommendations. For further information see the state fiscal estimate, which will be printed as an appendix to this bill. | In Committee |
| SB187 | Study of guaranteed employment grant program and making an appropriation. (FE) | This bill requires the Department of Workforce Development to study the creation of a job guarantee and full employment grant program. Under the program, DWD and municipalities provide grants to public and nonprofit employers in the care economy to provide certain job opportunities in positions covered by a collective bargaining unit to individuals with disabilities, heads of households with incomes that are 150 percent or less than the federal poverty line, individuals who have been unemployed for extended periods, individuals who were previously incarcerated, and individuals between 18 and 24 years old. The bill requires DWD to submit a report with the findings and recommendations. For further information see the state fiscal estimate, which will be printed as an appendix to this bill. | In Committee |
| SJR40 | Recognizing Asian American and Native Hawaiian/Pacific Islander (AANHPI) Heritage Month as a time to honor the important contributions of Asians, Asian Americans, Native Hawaiians, and Pacific Islanders to the history of the United States. | Relating to: recognizing Asian American and Native Hawaiian/Pacific Islander (AANHPI) Heritage Month as a time to honor the important contributions of Asians, Asian Americans, Native Hawaiians, and Pacific Islanders to the history of the United States. | In Committee |
| SB250 | Prohibiting abandonment of a boat and providing a penalty. | This bill prohibits a person from abandoning a boat on the waters of this state or upon adjacent riparian land. XAbandonY is defined to mean 1) leaving a boat unattended, without demonstrated intent to return to or moor or maintain the boat, for a period of more than seven consecutive days, or 2) leaving a boat that is partially submerged, in a state of disrepair, or otherwise neglected such that the boat presents a hazard to navigation, public safety, or environmental health and the owner has failed to take reasonable actions to remove or maintain the boat. Under the bill, if a law enforcement officer determines that a boat has been abandoned, the officer must notify the owner, who must remove the boat within 30 days. If the boat remains abandoned after that period, the owner is subject to imprisonment for up to nine months and a fine of up to $10,000, or both. In addition, the Department of Natural Resources shall require the person to obtain a certificate of satisfactory completion of a safety course before operating a boat. | In Committee |
| SJR47 | Observing Tuesday, March 25, 2025, as Equal Pay Day in Wisconsin. | Relating to: observing Tuesday, March 25, 2025, as Equal Pay Day in Wisconsin. | In Committee |
| SJR50 | Congratulating the Milwaukee Rufus King Cheer and Stunt Team on their double state championship win in 2025. | Relating to: congratulating the Milwaukee Rufus King Cheer and Stunt Team on their double state championship win in 2025. | In Committee |
| SJR46 | Honoring the life and public service of Representative Frederick P. Kessler. | Relating to: honoring the life and public service of Representative Frederick P. Kessler. | In Committee |
| AJR52 | Proclaiming April 20 to 26 as 2025 National Infertility Awareness Week in Wisconsin. | Relating to: proclaiming April 20 to 26 as 2025 National Infertility Awareness Week in Wisconsin. | In Committee |
| AJR54 | Observing Tuesday, March 25, 2025, as Equal Pay Day in Wisconsin. | Relating to: observing Tuesday, March 25, 2025, as Equal Pay Day in Wisconsin. | In Committee |
| AB249 | Prohibiting abandonment of a boat and providing a penalty. | This bill prohibits a person from abandoning a boat on the waters of this state or upon adjacent riparian land. XAbandonY is defined to mean 1) leaving a boat unattended, without demonstrated intent to return to or moor or maintain the boat, for a period of more than seven consecutive days, or 2) leaving a boat that is partially submerged, in a state of disrepair, or otherwise neglected such that the boat presents a hazard to navigation, public safety, or environmental health and the owner has failed to take reasonable actions to remove or maintain the boat. Under the bill, if a law enforcement officer determines that a boat has been abandoned, the officer must notify the owner, who must remove the boat within 30 days. If the boat remains abandoned after that period, the owner is subject to imprisonment for up to nine months and a fine of up to $10,000, or both. In addition, the Department of Natural Resources shall require the person to obtain a certificate of satisfactory completion of a safety course before operating a boat. | In Committee |
| SB105 | Jailers and protective occupation annuitants in the Wisconsin Retirement System who are rehired by a participating employer. (FE) | Under current law, certain persons who receive a retirement or disability annuity from the Wisconsin Retirement System and who are hired by an employer that participates in the WRS must suspend that annuity and may not receive a WRS annuity payment until the employee is no longer in a WRS-covered position. This suspension applies to a person who 1) has reached his or her normal retirement date; 2) is appointed to a position with a WRS-participating employer or provides employee services to a WRS-participating employer; and 3) is expected to work at least two-thirds of what is considered full-time employment by the Department of Employee Trust Funds. This bill creates an exception to this suspension for an annuitant who retired from employment with a participating employer and who is subsequently rehired or provides employee services after retirement if 1) at the time the annuitant initially retires from covered employment with a participating employer, the annuitant does not have an agreement with any participating employer to return to employment; 2) LRB-2167/1 MIM:klm&emw 2025 - 2026 Legislature SENATE BILL 105 the annuitant elects to not become a participating employee at the time the annuitant is rehired or enters into a contract after retirement; and 3) either the annuitant retired as a protective occupation participant or the annuitant retired as a county jailer who was not a protective occupation participant under the WRS. Under current law, a county jailer has the opportunity to opt out of becoming a protective occupation participant under the WRS. The bill treats county jailers who opt out of becoming a protective occupation participant in the same manner as county jailers who are protective occupation participants. Because this bill relates to public employee retirement or pensions, it may be referred to the Joint Survey Committee on Retirement Systems for a report to be printed as an appendix to the bill. For further information see the local fiscal estimate, which will be printed as an appendix to this bill. | In Committee |
| AJR42 | An advisory referendum on an amendment to the U.S. Constitution. | Relating to: an advisory referendum on an amendment to the U.S. Constitution. | In Committee |
| AJR38 | Proclaiming 2025 as the year of the snake. | Relating to: proclaiming 2025 as the year of the snake. | In Committee |
| AJR44 | Honoring the life and public service of Representative Frederick P. Kessler. | Relating to: honoring the life and public service of Representative Frederick P. Kessler. | In Committee |
| AJR36 | The right of the people to a clean, safe, and healthy natural environment and to its preservation (first consideration). | relating to: the right of the people to a clean, safe, and healthy natural environment and to its preservation (first consideration). | In Committee |
| SJR41 | Celebrating 50 years of strength and resilience of the Hmong, Lao, Cambodian, and Vietnamese people. | Relating to: celebrating 50 years of strength and resilience of the Hmong, Lao, Cambodian, and Vietnamese people. | In Committee |
| SJR8 | Proclaiming February 4, 2025, as Transit Equity Day. | Relating to: proclaiming February 4, 2025, as Transit Equity Day. | In Committee |
| AJR7 | Proclaiming February 4, 2025, as Transit Equity Day. | Relating to: proclaiming February 4, 2025, as Transit Equity Day. | In Committee |
| AB128 | Requiring first responders to be trained to administer epinephrine delivery systems. (FE) | This bill requires first responders to be trained in how to recognize signs and symptoms of severe allergic reactions, standards and procedures for the storage and administration of an epinephrine delivery system, and emergency follow-up procedures after an epinephrine delivery system is administered and requires first responders to have an epinephrine delivery system available to the first responder for use at all times while on duty. First responders include conservation wardens, correctional officers, emergency medical responders, emergency medical services practitioners, firefighters, and law enforcement officers. The Department of Health Services is required to identify organizations that conduct trainings that cover all the subjects that first responders are required to be trained in under the bill. Finally, the bill allows DHS to distribute epinephrine delivery systems to first responders who are trained in all subjects described under the bill or to employers of first responders who are trained in all subjects described under the bill to be used by those first responders. For further information see the state and local fiscal estimate, which will be printed as an appendix to this bill. | In Committee |
| SJR38 | An advisory referendum on an amendment to the U.S. Constitution. | Relating to: an advisory referendum on an amendment to the U.S. Constitution. | In Committee |
| SJR37 | The right of the people to a clean, safe, and healthy natural environment and to its preservation (first consideration). | relating to: the right of the people to a clean, safe, and healthy natural environment and to its preservation (first consideration). | In Committee |
| AJR23 | Designating April 2025 and April 2026 as Parkinson’s Disease Awareness Months. | Relating to: designating April 2025 and April 2026 as Parkinson[s Disease Awareness Months. | In Committee |
| AJR26 | Honoring the life and public service of Senator Timothy Francis Cullen. | Relating to: honoring the life and public service of Senator Timothy Francis Cullen. | In Committee |
| SJR21 | Honoring the life and public service of Senator Timothy Francis Cullen. | Relating to: honoring the life and public service of Senator Timothy Francis Cullen. | In Committee |
| SB156 | Requiring first responders to be trained to administer epinephrine delivery systems. (FE) | This bill requires first responders to be trained in how to recognize signs and symptoms of severe allergic reactions, standards and procedures for the storage and administration of an epinephrine delivery system, and emergency follow-up procedures after an epinephrine delivery system is administered and requires first responders to have an epinephrine delivery system available to the first responder for use at all times while on duty. First responders include conservation wardens, correctional officers, emergency medical responders, emergency medical services practitioners, firefighters, and law enforcement officers. The Department of Health Services is required to identify organizations that conduct trainings that cover all the subjects that first responders are required to be trained in under the bill. Finally, the bill allows DHS to distribute epinephrine delivery systems to first responders who are trained in all subjects described under the bill or to employers of first responders who are trained in all subjects described under the bill to be used by those first responders. For further information see the state and local fiscal estimate, which will be printed as an appendix to this bill. LRB-1317/1 JPC:emw 2025 - 2026 Legislature SENATE BILL 156 | In Committee |
| AJR19 | Honoring April 22, 2025, as the 55th anniversary of Earth Day. | Relating to: honoring April 22, 2025, as the 55th anniversary of Earth Day. | Crossed Over |
| SJR29 | Designating April 2025 and April 2026 as Parkinson’s Disease Awareness Months. | Relating to: designating April 2025 and April 2026 as Parkinson[s Disease Awareness Months. | Signed/Enacted/Adopted |
| AJR27 | Condemning the pardons and sentence commutations of individuals involved in the violent attack on law enforcement officers at the U.S. Capitol on January 6, 2021. | Relating to: condemning the pardons and sentence commutations of individuals involved in the violent attack on law enforcement officers at the U.S. Capitol on January 6, 2021. | In Committee |
| AB79 | Prosecuting or adjudicating delinquent a person under the age of 18 for committing an act of prostitution. | Under current law, a person who is under the age of 18 may be prosecuted or adjudicated delinquent for committing an act of prostitution, a Class A misdemeanor. Under this bill, a person who is under the age of 18 may not be prosecuted or adjudicated delinquent for committing an act of prostitution. This bill also eliminates the option under current law in cases where a person under the age of 18 has committed an act of prostitution for a court to enter a consent decree under the Juvenile Justice Code, or a deferred prosecution agreement under the Juvenile Justice Code or adult criminal statutes, if the court determines that a consent decree or deferred prosecution agreement will serve the best interests of the person being prosecuted and will not harm society. | In Committee |
| SJR20 | Honoring the life and public service of Representative Jim Soletski. | Relating to: honoring the life and public service of Representative Jim Soletski. | In Committee |
| SB70 | A minor’s authority to consent to health care. | This bill allows a minor who is an unaccompanied youth to consent to, contract for, and receive medically necessary care without a parent[s or guardian[s permission, authority, or consent under certain circumstances. The bill defines Xunaccompanied youthY as the term is defined under federal law, which is a homeless youth not in the physical custody of a parent or guardian. The bill defines Xmedically necessary careY as a medical service that is required to prevent, identify, or treat a recipient[s illness, injury, or disability and that meets a set of standards specified in the bill. Under the bill, in order to consent to health care, such a minor must be at least 14 years of age and must not be under the supervision of a county department of human services or social services, a licensed child welfare agency, the Department of Children and Families, or the Department of Corrections. Also under the bill, one of the following must confirm in writing that the minor is an unaccompanied youth: a local educational agency liaison for homeless children and youths designated under federal law, a school social worker or counselor, an employee who conducts intake at a shelter facility or transitional living program where the minor has been admitted as an unaccompanied youth under current law, or the director, or his or her designee, of a governmental or nonprofit entity that receives public or LRB-0487/1 EHS:cdc 2025 - 2026 Legislature SENATE BILL 70 private funding to provide services to individuals who are homeless or to unaccompanied youth. Under the bill, a professional who provides medically necessary care to a minor based on the minor[s consent given in conformity with the bill may not be held liable in a civil or criminal action for providing those services without having obtained permission from the minor[s parent or guardian. | In Committee |
| AB49 | A minor’s authority to consent to health care. | This bill allows a minor who is an unaccompanied youth to consent to, contract for, and receive medically necessary care without a parent[s or guardian[s permission, authority, or consent under certain circumstances. The bill defines Xunaccompanied youthY as the term is defined under federal law, which is a homeless youth not in the physical custody of a parent or guardian. The bill defines Xmedically necessary careY as a medical service that is required to prevent, identify, or treat a recipient[s illness, injury, or disability and that meets a set of standards specified in the bill. Under the bill, in order to consent to health care, such a minor must be at least 14 years of age and must not be under the supervision of a county department of human services or social services, a licensed child welfare agency, the Department of Children and Families, or the Department of Corrections. Also under the bill, one of the following must confirm in writing that the minor is an unaccompanied youth: a local educational agency liaison for homeless children and youths designated under federal law, a school social worker or counselor, an employee who conducts intake at a shelter facility or transitional living program where the minor has been admitted as an unaccompanied youth under current law, or the director, or his or her designee, of a governmental or nonprofit entity that receives public or private funding to provide services to individuals who are homeless or to unaccompanied youth. Under the bill, a professional who provides medically necessary care to a minor based on the minor[s consent given in conformity with the bill may not be held liable in a civil or criminal action for providing those services without having obtained permission from the minor[s parent or guardian. | In Committee |
| AJR5 | Proclaiming February 2025 as Black History Month. | Relating to: proclaiming February 2025 as Black History Month. | Signed/Enacted/Adopted |
| AJR15 | Proclaiming March 26, 2025, as Purple Day for epilepsy. | Relating to: proclaiming March 26, 2025, as Purple Day for epilepsy. | Crossed Over |
| SR2 | Proclaiming March 2025 and March 2026 as Women’s History Months. | Relating to: proclaiming March 2025 and March 2026 as Women[s History Months. | In Committee |
| SJR19 | Honoring the life and public service of Representative Jonathan Brostoff. | Relating to: honoring the life and public service of Representative Jonathan Brostoff. | In Committee |
| SB135 | Special observance days in schools. | This bill adds February 18, Vel R. Phillips[s birthday, to the list of special observance days that apply to general school operations. Current law provides a list of 22 special observance days, including Dr. Martin Luther King, Jr. Day; Susan B. Anthony[s birthday; Environmental Awareness Day; Bullying Awareness Day; and Veterans Day. Under current law, a special observance day must be appropriately observed when school is held on that day or, if the day falls on a Saturday or Sunday, on the school day immediately preceding or following the special observance day. | In Committee |
| SJR17 | Honoring April 22, 2025, as the 55th anniversary of Earth Day. | Relating to: honoring April 22, 2025, as the 55th anniversary of Earth Day. | In Committee |
| AB125 | Special observance days in schools. | This bill adds February 18, Vel R. Phillips[s birthday, to the list of special observance days that apply to general school operations. Current law provides a list of 22 special observance days, including Dr. Martin Luther King, Jr. Day; Susan B. Anthony[s birthday; Environmental Awareness Day; Bullying Awareness Day; and Veterans Day. Under current law, a special observance day must be appropriately observed when school is held on that day or, if the day falls on a Saturday or Sunday, on the school day immediately preceding or following the special observance day. | In Committee |
| AB52 | Expanding the homestead income tax credit. (FE) | Under current law, the homestead tax credit is a refundable income tax credit that may be claimed by homeowners and renters. The credit is based on the claimant[s household income and the amount of property taxes or rent constituting property taxes on his or her Wisconsin homestead. Because the credit is refundable, if the credit exceeds the claimant[s income tax liability, he or she receives the excess as a refund check. Under current law, there are three key dollar amounts used when calculating the credit: 1. If household income is $8,060 or less, the credit is 80 percent of the property taxes or rent constituting property taxes. If household income exceeds $8,060, the property taxes or rent constituting property taxes are reduced by 8.785 percent of the household income exceeding $8,060, and the credit is 80 percent of the reduced property taxes or rent constituting property taxes. 2. The credit may not be claimed if household income exceeds $24,680. 3. The maximum property taxes or rent constituting property taxes used to calculate the credit is $1,460. Beginning with claims filed for the 2025 tax year, this bill reduces the percentage used for household income over $8,060 from 8.785 to 5.614 percent and increases the maximum income amount from $24,680 to $35,000. The bill also indexes the $8,060, $35,000, and $1,460 amounts for inflation during future tax years. For further information see the state fiscal estimate, which will be printed as an appendix to this bill. | In Committee |
| SB60 | Expanding the homestead income tax credit. (FE) | Under current law, the homestead tax credit is a refundable income tax credit that may be claimed by homeowners and renters. The credit is based on the claimant[s household income and the amount of property taxes or rent constituting property taxes on his or her Wisconsin homestead. Because the credit is refundable, if the credit exceeds the claimant[s income tax liability, he or she receives the excess as a refund check. Under current law, there are three key dollar amounts used when calculating the credit: 1. If household income is $8,060 or less, the credit is 80 percent of the property taxes or rent constituting property taxes. If household income exceeds $8,060, the property taxes or rent constituting property taxes are reduced by 8.785 percent of the household income exceeding $8,060, and the credit is 80 percent of the reduced property taxes or rent constituting property taxes. 2. The credit may not be claimed if household income exceeds $24,680. LRB-2169/1 KP:cdc 2025 - 2026 Legislature SENATE BILL 60 3. The maximum property taxes or rent constituting property taxes used to calculate the credit is $1,460. Beginning with claims filed for the 2025 tax year, this bill reduces the percentage used for household income over $8,060 from 8.785 to 5.614 percent and increases the maximum income amount from $24,680 to $35,000. The bill also indexes the $8,060, $35,000, and $1,460 amounts for inflation during future tax years. For further information see the state fiscal estimate, which will be printed as an appendix to this bill. | In Committee |
| SJR15 | Condemning the pardons and sentence commutations of individuals involved in the violent attack on law enforcement officers at the U.S. Capitol on January 6, 2021. | Relating to: condemning the pardons and sentence commutations of individuals involved in the violent attack on law enforcement officers at the U.S. Capitol on January 6, 2021. | In Committee |
| SJR13 | Honoring the life and public service of Assembly Chief Clerk Patrick Fuller. | Relating to: honoring the life and public service of Assembly Chief Clerk Patrick Fuller. | In Committee |
| AB48 | Providing state aid to reimburse public and private schools that provide free meals to all pupils for the costs of those meals and making an appropriation. (FE) | This bill provides additional state aid to public and private schools in this state that provide free meals to all pupils. Under current law, the Department of Public Instruction makes payments to school districts, private schools, independent charter schools, tribal schools, the Wisconsin Educational Services Program for the Deaf and Hard of Hearing, and the Wisconsin Center for the Blind and Visually Impaired to partially match the federal contribution under the National School Lunch Program, under which schools provide free or reduced-price lunches to low-income children. Currently, the state share for school lunches is a variable percentage of the amount of the federal basic reimbursement, which is then allocated among eligible schools according to the number of lunches served during the prior school year. Also under current law, DPI provides a per meal reimbursement to school districts, private schools, and tribal schools that provide breakfast to pupils under the federal School Breakfast Program. Currently, the state provides a per meal reimbursement of $0.15 for each breakfast served under the program, but, if there is insufficient funding to pay the full amount, DPI prorates the payments. Under the bill, a school is eligible for additional state reimbursement for lunches and breakfasts served in a school year if the school 1) participates in both the National School Lunch Program and the federal School Breakfast Program for the school year; and 2) for each school day in which school is in session during the school year, provides to any pupil who requests one, at no cost to the pupil, one lunch and one breakfast that meet the federal food, nutritional, and other requirements for meals served under the federal programs. Under the bill, DPI must reimburse an eligible school a per meal amount that is equal to the federal reimbursement rate applicable to the eligible school under the applicable federal program for a meal served to a pupil who satisfies the income eligibility criteria for a free lunch, minus any amount the eligible school receives from the federal government to pay for those meals. In other words, the bill guarantees that an eligible school will receive a total amount in state and federal aid that will reimburse the eligible school an amount equal to the free meal reimbursement rate for each meal the eligible school serves. The additional state reimbursement under the bill is available to school districts, independent charter schools, private schools, tribal schools, residential care centers for children and youth, the Wisconsin Educational Services Program for the Deaf and Hard of Hearing, and the Wisconsin Center for the Blind and Visually Impaired that meet the eligibility requirements. Under the bill, if a school does not meet the eligibility requirements for the additional state reimbursement for a school year, all of the following apply: 1. If the school participates in the National School Lunch Program for the school year, DPI will reimburse the school an amount required to meet the state[s matching obligation under the federal program. 2. If the school participates in the federal School Breakfast Program for the school year, DPI will reimburse the school $0.15 for each breakfast served under the federal program, without proration. For further information see the state and local fiscal estimate, which will be printed as an appendix to this bill. | In Committee |
| SB67 | Providing state aid to reimburse public and private schools that provide free meals to all pupils for the costs of those meals and making an appropriation. (FE) | This bill provides additional state aid to public and private schools in this state that provide free meals to all pupils. Under current law, the Department of Public Instruction makes payments to school districts, private schools, independent charter schools, tribal schools, the Wisconsin Educational Services Program for the Deaf and Hard of Hearing, and the Wisconsin Center for the Blind and Visually Impaired to partially match the federal contribution under the National School Lunch Program, under which schools provide free or reduced-price lunches to low-income children. Currently, the state share for school lunches is a variable percentage of the amount of the federal basic LRB-2213/1 KMS:amn 2025 - 2026 Legislature SENATE BILL 67 reimbursement, which is then allocated among eligible schools according to the number of lunches served during the prior school year. Also under current law, DPI provides a per meal reimbursement to school districts, private schools, and tribal schools that provide breakfast to pupils under the federal School Breakfast Program. Currently, the state provides a per meal reimbursement of $0.15 for each breakfast served under the program, but, if there is insufficient funding to pay the full amount, DPI prorates the payments. Under the bill, a school is eligible for additional state reimbursement for lunches and breakfasts served in a school year if the school 1) participates in both the National School Lunch Program and the federal School Breakfast Program for the school year; and 2) for each school day in which school is in session during the school year, provides to any pupil who requests one, at no cost to the pupil, one lunch and one breakfast that meet the federal food, nutritional, and other requirements for meals served under the federal programs. Under the bill, DPI must reimburse an eligible school a per meal amount that is equal to the federal reimbursement rate applicable to the eligible school under the applicable federal program for a meal served to a pupil who satisfies the income eligibility criteria for a free lunch, minus any amount the eligible school receives from the federal government to pay for those meals. In other words, the bill guarantees that an eligible school will receive a total amount in state and federal aid that will reimburse the eligible school an amount equal to the free meal reimbursement rate for each meal the eligible school serves. The additional state reimbursement under the bill is available to school districts, independent charter schools, private schools, tribal schools, residential care centers for children and youth, the Wisconsin Educational Services Program for the Deaf and Hard of Hearing, and the Wisconsin Center for the Blind and Visually Impaired that meet the eligibility requirements. Under the bill, if a school does not meet the eligibility requirements for the additional state reimbursement for a school year, all of the following apply: 1. If the school participates in the National School Lunch Program for the school year, DPI will reimburse the school an amount required to meet the state[s matching obligation under the federal program. 2. If the school participates in the federal School Breakfast Program for the school year, DPI will reimburse the school $0.15 for each breakfast served under the federal program, without proration. For further information see the state and local fiscal estimate, which will be printed as an appendix to this bill. | In Committee |
| AJR11 | Honoring the life and public service of Representative Jim Soletski. | Relating to: honoring the life and public service of Representative Jim Soletski. | In Committee |
| AB62 | Health care costs omnibus, granting rule-making authority, making an appropriation, and providing a penalty. (FE) | Elimination of cost sharing for prescription drugs under the Medical Assistance program Under current law, certain persons who receive health services under the Medical Assistance program, also known in this state as BadgerCare, are required to contribute a cost-sharing payment to the cost of certain health services. This bill eliminates all cost-sharing payments for prescription drugs under the Medical Assistance program. The Medical Assistance program is a joint state and federal program that provides health services to individuals who have limited financial resources. Cost-sharing cap on insulin The bill prohibits every health insurance policy and governmental self-insured health plan that covers insulin and imposes cost sharing on prescription drugs from imposing cost sharing on insulin in an amount that exceeds $35 for a one-month supply. Current law requires every health insurance policy that provides coverage of expenses incurred for treatment of diabetes to provide coverage for specified expenses and items, including insulin. The required coverage under current law for certain diabetes treatments other than insulin infusion pumps is subject to the same exclusions, limitations, deductibles, and coinsurance provisions of the policy as other covered expenses. The bill[s cost-sharing limitation on insulin supersedes the specification that the exclusions, limitations, deductibles, and coinsurance are the same as for other coverage. Fiduciary and disclosure requirements for pharmacy benefit managers The bill imposes fiduciary and disclosure requirements on pharmacy benefit managers. Pharmacy benefit managers contract with health plans that provide prescription drug benefits to administer those benefits for the plans. They also have contracts with pharmacies and pay the pharmacies for providing drugs to the plan beneficiaries. The bill provides that a pharmacy benefit manager owes a fiduciary duty to a health plan sponsor. The bill also requires that a pharmacy benefit manager annually disclose all of the following information to the plan sponsor: 1. The indirect profit received by the pharmacy benefit manager from owning a pharmacy or service provider. 2. Any payments made to a consultant or broker who works on behalf of the plan sponsor. 3. From the amounts received from drug manufacturers, the amounts retained by the pharmacy benefit manager that are related to the plan sponsor[s claims or bona fide service fees. 4. The amounts received from network pharmacies and the amount retained by the pharmacy benefit manager. Reimbursements for certain 340B program entities The bill prohibits any person from reimbursing certain entities that participate in the federal drug pricing program, known as the 340B program, for a drug subject to an agreement under the program at a rate lower than that paid for the same drug to pharmacies that have a similar prescription volume. The bill also prohibits a person from imposing any fee, charge back, or other adjustment on the basis of the entity[s participation in the 340B program. The entities covered by the prohibitions under the bill are federally qualified health centers, critical access hospitals, and grantees under the federal Ryan White HIV/AIDS program, as well as these entities[ pharmacies and any pharmacy with which any of the entities have contracted to dispense drugs through the 340B program. Drug repository program Under current law, the Department of Health Services must maintain a drug repository program under which any person may donate certain drugs or supplies to be dispensed to and used by eligible individuals, prioritizing uninsured and indigent individuals. The bill allows DHS to partner with out-of-state drug repository programs. The bill also allows out-of-state persons to donate to the drug repository program in Wisconsin and persons in Wisconsin to donate to participating drug repository programs in other states. Further, the bill directs DHS to study and implement a centralized, physical drug repository program. Value-based diabetes medication pilot project The bill directs the Office of the Commissioner of Insurance to develop a pilot project under which a pharmacy benefit manager and pharmaceutical manufacturer are directed to create a value-based, sole-source arrangement to reduce the costs of prescription diabetes medication. The bill allows OCI to promulgate rules to implement the pilot project. Pharmacist continuing education credits for volunteering at free and charitable clinics Under current law, a licensed pharmacist must renew his or her license every two years. An applicant for renewal of a pharmacist license must submit proof that he or she has completed 30 hours of continuing education within the two-year period immediately preceding the date of his or her application. The bill allows pharmacists to meet up to 10 hours of the continuing education requirement for each two-year period by volunteering at a free and charitable clinic approved by the Pharmacy Examining Board. Prescription drug importation program The bill requires the commissioner of insurance, in consultation with persons interested in the sale and pricing of prescription drugs and federal officials and agencies, to design and implement a prescription drug importation program for the benefit of and that generates savings for Wisconsin residents. The bill establishes requirements for the program, including all of the following: 1. The commissioner must designate a state agency to become a licensed wholesale distributor or contract with a licensed wholesale distributor and to seek federal certification and approval to import prescription drugs. 2. The program must comply with certain federal regulations and import from Canadian suppliers only prescription drugs that are not brand-name drugs, have fewer than four competitor drugs in this country, and for which importation creates substantial savings. 3. The commissioner must ensure that prescription drugs imported under the program are not distributed, dispensed, or sold outside of Wisconsin. 4. The program must have an audit procedure to ensure the program complies with certain requirements specified in the bill. Before submitting the proposed program to the federal government for certification, the commissioner must submit the proposed program to the Joint Committee on Finance for its approval. Pharmacy benefits tool grants The bill directs OCI to award grants in an amount of up to $500,000 in each fiscal year to health care providers to develop and implement a patient pharmacy benefits tool that would allow prescribers to disclose the cost of prescription drugs for patients. The tool must be usable by physicians and other prescribers to determine the cost of prescription drugs for their patients. Any health care provider that receives a grant to develop and implement a patient pharmacy benefits tool is required to contribute matching funds equal to at least 50 percent of the total grant awarded. Prescription drug purchasing entity study The bill requires OCI to conduct a study on the viability of creating or implementing a state prescription drug purchasing entity. Licensure of pharmacy services administrative organizations The bill requires that a pharmacy services administrative organization (PSAO) be licensed by OCI. Under the bill, a PSAO is an entity operating in Wisconsin that does all of the following: 1. Contracts with an independent pharmacy to conduct business on the pharmacy[s behalf with a third-party payer. 2. Provides at least one administrative service to an independent pharmacy and negotiates and enters into a contract with a third-party payer or pharmacy benefit manager on the pharmacy[s behalf. The bill defines Xindependent pharmacyY to mean a licensed pharmacy operating in Wisconsin that is under common ownership with no more than two other pharmacies. XAdministrative serviceY is defined to mean assisting with claims or audits, providing centralized payment, performing certification in a specialized care program, providing compliance support, setting flat fees for generic drugs, assisting with store layout, managing inventory, providing marketing support, providing management and analysis of payment and drug dispensing data, or providing resources for retail cash cards. The bill defines Xthird-party payerY to mean an entity operating in Wisconsin that pays or insures health, medical, or prescription drug expenses on behalf of beneficiaries. The bill uses the current law definition of Xpharmacy benefit manager,Y which is an entity doing business in Wisconsin that contracts to administer or manage prescription drug benefits on behalf of an insurer or other entity that provides prescription drug benefits to Wisconsin residents. To obtain the license required by the bill, a person must apply to OCI and provide the contact information for the applicant and a contact person, evidence of financial responsibility of at least $1,000,000, and any other information required by the commissioner by rule. Under the bill, the license fee is set by the commissioner, and the term of a license is two years. The bill also requires that a PSAO disclose to OCI the extent of any ownership or control by an entity that provides pharmacy services; provides prescription drug or device services; or manufactures, sells, or distributes prescription drugs, biologicals, or medical devices. The PSAO must notify OCI within five days of any material change in its ownership or control related to such an entity. Licensure of pharmaceutical representatives The bill requires a pharmaceutical representative to be licensed by OCI and to display the pharmaceutical representative[s license during each visit with a health care professional. The bill defines Xpharmaceutical representativeY to mean an individual who markets or promotes pharmaceuticals to health care professionals on behalf of a pharmaceutical manufacturer for compensation. The term of a license issued under the bill is one year, and the license is renewable. The application to obtain or renew a license must include the applicant[s contact information, a description of the type of work in which the applicant will engage, the license fee, an attestation that professional education requirements are met, proof that any penalties and other fees are paid, and any other information required by OCI by rule. Under the bill, the license fee is set by the commissioner. The bill requires the pharmaceutical representative to report, within four business days, any change to the information provided on the application or any material change to the pharmaceutical representative[s business operations or other information required to be reported under the bill. The bill requires that a pharmaceutical representative complete a professional education course prior to becoming licensed and to annually complete at least five hours of continuing professional education courses. The coursework must include, at a minimum, training in ethical standards, whistleblower protections, and the laws and rules applicable to pharmaceutical marketing. The bill directs the commissioner to regularly publish a list of courses that fulfill the education requirements. Under the bill, a course provider must disclose any conflict of interest to the commissioner, and the courses may not be provided by the employer of a pharmaceutical representative or be funded by the pharmaceutical industry or a third party funded by the industry. The bill requires that, no later than June 1 of each year, a pharmaceutical representative report to OCI the pharmaceutical representative[s total number of contacts with health care professionals in Wisconsin, the specialties of those health care professionals, the location and duration of each contact, the pharmaceuticals discussed, and the value of any item provided to a health care professional. The bill directs the commissioner to publish the information on OCI[s website without identifying individual health care professionals. The bill requires that a pharmaceutical representative, during each contact with a health care professional, disclose the wholesale acquisition cost of any pharmaceuticals discussed and the names of at least three generic prescription drugs from the same therapeutic class. The bill directs the commissioner to promulgate ethical standards for pharmaceutical representatives. Additionally, the bill prohibits a pharmaceutical representative from engaging in deceptive or misleading marketing of a pharmaceutical product; using a title or designation that could reasonably lead a licensed health care professional, or an employee or representative of such a professional, to believe that the pharmaceutical representative is licensed to practice in a health occupation unless the pharmaceutical representative holds a license to practice in that health occupation; or attending a patient examination without the patient[s consent. An individual who violates any of the requirements under the bill is subject to a forfeiture, and the individual[s license may be suspended or revoked. An individual whose license is revoked must wait at least two years before applying for a new license. Insulin safety net programs The bill requires insulin manufacturers to establish a program under which qualifying Wisconsin residents who are in urgent need of insulin and are uninsured or have limited insurance coverage can be dispensed insulin at a pharmacy. An individual is in urgent need of insulin if the individual needs insulin in order to avoid the likelihood of suffering a significant health consequence and possesses less than a seven-day supply of insulin readily available for use. Under the program, if a qualifying individual in urgent need of insulin provides a pharmacy with a form attesting that the individual meets the program[s eligibility requirements, specified proof of residency, and a valid insulin prescription, the pharmacy must dispense a 30-day supply of insulin to the individual and may charge the individual a copayment of no more than $35. The pharmacy may submit an electronic payment claim for the insulin[s acquisition cost to the manufacturer or agree to receive a replacement of the same insulin in the amount dispensed. The bill also requires that each insulin manufacturer establish a patient assistance program to make insulin available to any qualifying Wisconsin resident who, among other requirements, is uninsured or has limited insurance coverage and whose family income does not exceed 400 percent of the federal poverty line. Under the bill, an individual must apply to participate in a manufacturer[s program. If the manufacturer determines that the individual meets the program[s eligibility requirements, the manufacturer must issue the individual a statement of eligibility, which is valid for 12 months and may be renewed. Under the bill, if an individual with a statement of eligibility and valid insulin prescription requests insulin from a pharmacy, the pharmacy must submit an order to the manufacturer, who must then provide a 90-day supply of insulin at no charge to the individual or pharmacy. The pharmacy may charge the individual a copayment of no more than $50. Under the bill, a manufacturer is not required to issue a statement of eligibility if the individual has prescription drug coverage through an individual or group health plan and the manufacturer determines that the individual[s insulin needs are better addressed through the manufacturer[s copayment assistance program. In such case, the manufacturer must provide the individual with necessary drug coupons to submit to a pharmacy, and the individual may not be required to pay more than a $50 copayment for a 90-day supply of insulin. Under the bill, if the manufacturer determines that an individual is not eligible for the patient assistance program, the individual may file an appeal with OCI. The bill directs OCI to establish procedures for deciding appeals. Under the bill, OCI must issue a decision within 10 days, and that decision is final. The bill requires that insulin manufacturers annually report to OCI certain information, including the number of individuals served and the cost of insulin dispensed under the programs and that OCI annually report to the governor and the legislature on the programs. The bill also directs OCI to conduct public outreach and develop an information sheet about the programs, conduct satisfaction surveys of individuals and pharmacies that participate in the programs, and report to the governor and the legislature on the surveys by July 1, 2028. Additionally, the bill requires that OCI develop a training program for health care navigators to assist individuals in accessing appropriate long-term insulin options and maintain a list of trained navigators. The bill provides that a manufacturer that fails to comply with the bill[s provisions may be assessed a forfeiture of up to noncompliance, which increases to $400,000 per month if the manufacturer continues to be in noncompliance after six months and to $600,000 per month if the manufacturer continues to be in noncompliance after one year. The bill[s requirements do not apply to manufacturers with annual insulin sales revenue in Wisconsin of no more than $2,000,000 or to insulin that costs less than a specified dollar amount. Prescription Drug Affordability Review Board The bill creates a Prescription Drug Affordability Review Board, whose purpose is to protect Wisconsin residents and other stakeholders from the high costs of prescription drugs. The board consists of the commissioner of insurance and the following members, all of whom are appointed by the governor for four-year terms: 1. Two members who represent the pharmaceutical drug industry, at least one of whom is a licensed pharmacist. 2. Two members who represent the health insurance industry. 3. Two members who represent the health care industry, at least one of whom is a licensed practitioner. 4. Two members who represent the interests of the public. The bill requires the board to meet in open session at least four times per year to review prescription drug pricing information. The board must provide at least two weeks[ public notice of each meeting, make the meeting[s materials publicly available at least one week prior to the meeting, and provide the opportunity for public comment. The bill imposes conflict of interest requirements for the board relating to recusal and public disclosure of certain conflicts. The bill directs the board to access and assess drug pricing information, to the extent practicable, by accessing and assessing information from other states, by assessing spending for the drug in Wisconsin, and by accessing other available pricing information. Under the bill, the board must conduct drug cost affordability reviews. The board must identify prescription drugs whose launch wholesale acquisition cost exceeds specified thresholds, prescription drugs whose increase in wholesale acquisition cost exceeds specified thresholds, and other prescription drugs that may create affordability challenges for the health care system in Wisconsin. For each identified prescription drug, the board must determine whether to conduct an affordability review by seeking stakeholder input and considering the average patient cost share for the drug. During an affordability review, the board must determine whether use of the prescription drug that is fully consistent with the labeling approved by the federal Food and Drug Administration or standard medical practice has led or will lead to an affordability challenge for the health care system in Wisconsin. In making this determination, the bill requires the board to consider a variety of factors, which include the following: 1. The drug[s wholesale acquisition cost. 2. The average monetary price concession, discount, or rebate the manufacturer provides, or is expected to provide, for the drug to health plans. 3. The total amount of price concessions, discounts, and rebates the manufacturer provides to each pharmacy benefit manager for the drug. 4. The price at which therapeutic alternatives have been sold and the average monetary concession, discount, or rebate the manufacturer provides, or is expected to provide, to health plan payors and pharmacy benefit managers for therapeutic alternatives. 5. The costs to health plans based on patient access consistent with federal labeled indications and recognized standard medical practice. 6. The impact on patient access resulting from the drug[s cost relative to insurance benefit design. 7. The current or expected dollar value of drug-specific patient access programs that are supported by the manufacturer. 8. The relative financial impacts to health, medical, or social services costs that can be quantified and compared to baseline effects of existing therapeutic alternatives. 9. The average patient copay or other cost sharing for the drug. If the board determines that a prescription drug will lead to an affordability challenge, the bill directs the board to establish an upper payment limit for that drug that applies to all purchases and payor reimbursements of the drug dispensed or administered to individuals in Wisconsin. In establishing the upper payment limit, the board must consider the cost of administering the drug, the cost of delivering it to consumers, and other relevant administrative costs. For certain drugs, the board must solicit information from the manufacturer regarding the price increase and, if the board determines that the price increase is not a result of the need for increased manufacturing capacity or other effort to improve patient access during a public health emergency, the board must establish an upper payment limit equal to the drug[s cost prior to the price increase. Further, this bill provides $500,000 in program revenue in fiscal year 2026]27 for onetime implementation costs associated with establishing an Office of Prescription Drug Affordability in OCI. The bill provides that the Office of Prescription Drug Affordability is responsible for prescription drug affordability programming within OCI and for overseeing the operations of the Prescription Drug Affordability Review Board. Additionally, the bill authorizes and funds for fiscal year 2026]27 16.0 positions for the Office of Prescription Drug Affordability. Finally, the bill credits to the appropriation account for OCI[s general program operations all moneys received from the regulation of pharmacy benefit managers, pharmacy benefit management brokers, pharmacy benefit management consultants, pharmacy services administrative organizations, and pharmaceutical sales representatives. This proposal may contain a health insurance mandate requiring a social and financial impact report under s. 601.423, stats. For further information see the state fiscal estimate, which will be printed as an appendix to this bill. | In Committee |
| SB50 | Health care costs omnibus, granting rule-making authority, making an appropriation, and providing a penalty. (FE) | Elimination of cost sharing for prescription drugs under the Medical Assistance program Under current law, certain persons who receive health services under the Medical Assistance program, also known in this state as BadgerCare, are required to contribute a cost-sharing payment to the cost of certain health services. This bill eliminates all cost-sharing payments for prescription drugs under the Medical LRB-1423/1 JPC:all 2025 - 2026 Legislature SENATE BILL 50 Assistance program. The Medical Assistance program is a joint state and federal program that provides health services to individuals who have limited financial resources. Cost-sharing cap on insulin The bill prohibits every health insurance policy and governmental self-insured health plan that covers insulin and imposes cost sharing on prescription drugs from imposing cost sharing on insulin in an amount that exceeds $35 for a one-month supply. Current law requires every health insurance policy that provides coverage of expenses incurred for treatment of diabetes to provide coverage for specified expenses and items, including insulin. The required coverage under current law for certain diabetes treatments other than insulin infusion pumps is subject to the same exclusions, limitations, deductibles, and coinsurance provisions of the policy as other covered expenses. The bill[s cost-sharing limitation on insulin supersedes the specification that the exclusions, limitations, deductibles, and coinsurance are the same as for other coverage. Fiduciary and disclosure requirements for pharmacy benefit managers The bill imposes fiduciary and disclosure requirements on pharmacy benefit managers. Pharmacy benefit managers contract with health plans that provide prescription drug benefits to administer those benefits for the plans. They also have contracts with pharmacies and pay the pharmacies for providing drugs to the plan beneficiaries. The bill provides that a pharmacy benefit manager owes a fiduciary duty to a health plan sponsor. The bill also requires that a pharmacy benefit manager annually disclose all of the following information to the plan sponsor: 1. The indirect profit received by the pharmacy benefit manager from owning a pharmacy or service provider. 2. Any payments made to a consultant or broker who works on behalf of the plan sponsor. 3. From the amounts received from drug manufacturers, the amounts retained by the pharmacy benefit manager that are related to the plan sponsor[s claims or bona fide service fees. 4. The amounts received from network pharmacies and the amount retained by the pharmacy benefit manager. Reimbursements for certain 340B program entities The bill prohibits any person from reimbursing certain entities that participate in the federal drug pricing program, known as the 340B program, for a drug subject to an agreement under the program at a rate lower than that paid for the same drug to pharmacies that have a similar prescription volume. The bill also prohibits a person from imposing any fee, charge back, or other adjustment on the basis of the entity[s participation in the 340B program. The entities covered by the prohibitions under the bill are federally qualified health centers, critical access hospitals, and grantees under the federal Ryan White HIV/AIDS program, as well LRB-1423/1 JPC:all 2025 - 2026 Legislature SENATE BILL 50 as these entities[ pharmacies and any pharmacy with which any of the entities have contracted to dispense drugs through the 340B program. Drug repository program Under current law, the Department of Health Services must maintain a drug repository program under which any person may donate certain drugs or supplies to be dispensed to and used by eligible individuals, prioritizing uninsured and indigent individuals. The bill allows DHS to partner with out-of-state drug repository programs. The bill also allows out-of-state persons to donate to the drug repository program in Wisconsin and persons in Wisconsin to donate to participating drug repository programs in other states. Further, the bill directs DHS to study and implement a centralized, physical drug repository program. Value-based diabetes medication pilot project The bill directs the Office of the Commissioner of Insurance to develop a pilot project under which a pharmacy benefit manager and pharmaceutical manufacturer are directed to create a value-based, sole-source arrangement to reduce the costs of prescription diabetes medication. The bill allows OCI to promulgate rules to implement the pilot project. Pharmacist continuing education credits for volunteering at free and charitable clinics Under current law, a licensed pharmacist must renew his or her license every two years. An applicant for renewal of a pharmacist license must submit proof that he or she has completed 30 hours of continuing education within the two-year period immediately preceding the date of his or her application. The bill allows pharmacists to meet up to 10 hours of the continuing education requirement for each two-year period by volunteering at a free and charitable clinic approved by the Pharmacy Examining Board. Prescription drug importation program The bill requires the commissioner of insurance, in consultation with persons interested in the sale and pricing of prescription drugs and federal officials and agencies, to design and implement a prescription drug importation program for the benefit of and that generates savings for Wisconsin residents. The bill establishes requirements for the program, including all of the following: 1. The commissioner must designate a state agency to become a licensed wholesale distributor or contract with a licensed wholesale distributor and to seek federal certification and approval to import prescription drugs. 2. The program must comply with certain federal regulations and import from Canadian suppliers only prescription drugs that are not brand-name drugs, have fewer than four competitor drugs in this country, and for which importation creates substantial savings. 3. The commissioner must ensure that prescription drugs imported under the program are not distributed, dispensed, or sold outside of Wisconsin. LRB-1423/1 JPC:all 2025 - 2026 Legislature SENATE BILL 50 4. The program must have an audit procedure to ensure the program complies with certain requirements specified in the bill. Before submitting the proposed program to the federal government for certification, the commissioner must submit the proposed program to the Joint Committee on Finance for its approval. Pharmacy benefits tool grants The bill directs OCI to award grants in an amount of up to $500,000 in each fiscal year to health care providers to develop and implement a patient pharmacy benefits tool that would allow prescribers to disclose the cost of prescription drugs for patients. The tool must be usable by physicians and other prescribers to determine the cost of prescription drugs for their patients. Any health care provider that receives a grant to develop and implement a patient pharmacy benefits tool is required to contribute matching funds equal to at least 50 percent of the total grant awarded. Prescription drug purchasing entity study The bill requires OCI to conduct a study on the viability of creating or implementing a state prescription drug purchasing entity. Licensure of pharmacy services administrative organizations The bill requires that a pharmacy services administrative organization (PSAO) be licensed by OCI. Under the bill, a PSAO is an entity operating in Wisconsin that does all of the following: 1. Contracts with an independent pharmacy to conduct business on the pharmacy[s behalf with a third-party payer. 2. Provides at least one administrative service to an independent pharmacy and negotiates and enters into a contract with a third-party payer or pharmacy benefit manager on the pharmacy[s behalf. The bill defines Xindependent pharmacyY to mean a licensed pharmacy operating in Wisconsin that is under common ownership with no more than two other pharmacies. XAdministrative serviceY is defined to mean assisting with claims or audits, providing centralized payment, performing certification in a specialized care program, providing compliance support, setting flat fees for generic drugs, assisting with store layout, managing inventory, providing marketing support, providing management and analysis of payment and drug dispensing data, or providing resources for retail cash cards. The bill defines Xthird-party payerY to mean an entity operating in Wisconsin that pays or insures health, medical, or prescription drug expenses on behalf of beneficiaries. The bill uses the current law definition of Xpharmacy benefit manager,Y which is an entity doing business in Wisconsin that contracts to administer or manage prescription drug benefits on behalf of an insurer or other entity that provides prescription drug benefits to Wisconsin residents. To obtain the license required by the bill, a person must apply to OCI and provide the contact information for the applicant and a contact person, evidence of LRB-1423/1 JPC:all 2025 - 2026 Legislature SENATE BILL 50 financial responsibility of at least $1,000,000, and any other information required by the commissioner by rule. Under the bill, the license fee is set by the commissioner, and the term of a license is two years. The bill also requires that a PSAO disclose to OCI the extent of any ownership or control by an entity that provides pharmacy services; provides prescription drug or device services; or manufactures, sells, or distributes prescription drugs, biologicals, or medical devices. The PSAO must notify OCI within five days of any material change in its ownership or control related to such an entity. Licensure of pharmaceutical representatives The bill requires a pharmaceutical representative to be licensed by OCI and to display the pharmaceutical representative[s license during each visit with a health care professional. The bill defines Xpharmaceutical representativeY to mean an individual who markets or promotes pharmaceuticals to health care professionals on behalf of a pharmaceutical manufacturer for compensation. The term of a license issued under the bill is one year, and the license is renewable. The application to obtain or renew a license must include the applicant[s contact information, a description of the type of work in which the applicant will engage, the license fee, an attestation that professional education requirements are met, proof that any penalties and other fees are paid, and any other information required by OCI by rule. Under the bill, the license fee is set by the commissioner. The bill requires the pharmaceutical representative to report, within four business days, any change to the information provided on the application or any material change to the pharmaceutical representative[s business operations or other information required to be reported under the bill. The bill requires that a pharmaceutical representative complete a professional education course prior to becoming licensed and to annually complete at least five hours of continuing professional education courses. The coursework must include, at a minimum, training in ethical standards, whistleblower protections, and the laws and rules applicable to pharmaceutical marketing. The bill directs the commissioner to regularly publish a list of courses that fulfill the education requirements. Under the bill, a course provider must disclose any conflict of interest to the commissioner, and the courses may not be provided by the employer of a pharmaceutical representative or be funded by the pharmaceutical industry or a third party funded by the industry. The bill requires that, no later than June 1 of each year, a pharmaceutical representative report to OCI the pharmaceutical representative[s total number of contacts with health care professionals in Wisconsin, the specialties of those health care professionals, the location and duration of each contact, the pharmaceuticals discussed, and the value of any item provided to a health care professional. The bill directs the commissioner to publish the information on OCI[s website without identifying individual health care professionals. The bill requires that a pharmaceutical representative, during each contact with a health care professional, disclose the wholesale acquisition cost of any LRB-1423/1 JPC:all 2025 - 2026 Legislature SENATE BILL 50 pharmaceuticals discussed and the names of at least three generic prescription drugs from the same therapeutic class. The bill directs the commissioner to promulgate ethical standards for pharmaceutical representatives. Additionally, the bill prohibits a pharmaceutical representative from engaging in deceptive or misleading marketing of a pharmaceutical product; using a title or designation that could reasonably lead a licensed health care professional, or an employee or representative of such a professional, to believe that the pharmaceutical representative is licensed to practice in a health occupation unless the pharmaceutical representative holds a license to practice in that health occupation; or attending a patient examination without the patient[s consent. An individual who violates any of the requirements under the bill is subject to a forfeiture, and the individual[s license may be suspended or revoked. An individual whose license is revoked must wait at least two years before applying for a new license. Insulin safety net programs The bill requires insulin manufacturers to establish a program under which qualifying Wisconsin residents who are in urgent need of insulin and are uninsured or have limited insurance coverage can be dispensed insulin at a pharmacy. An individual is in urgent need of insulin if the individual needs insulin in order to avoid the likelihood of suffering a significant health consequence and possesses less than a seven-day supply of insulin readily available for use. Under the program, if a qualifying individual in urgent need of insulin provides a pharmacy with a form attesting that the individual meets the program[s eligibility requirements, specified proof of residency, and a valid insulin prescription, the pharmacy must dispense a 30-day supply of insulin to the individual and may charge the individual a copayment of no more than $35. The pharmacy may submit an electronic payment claim for the insulin[s acquisition cost to the manufacturer or agree to receive a replacement of the same insulin in the amount dispensed. The bill also requires that each insulin manufacturer establish a patient assistance program to make insulin available to any qualifying Wisconsin resident who, among other requirements, is uninsured or has limited insurance coverage and whose family income does not exceed 400 percent of the federal poverty line. Under the bill, an individual must apply to participate in a manufacturer[s program. If the manufacturer determines that the individual meets the program[s eligibility requirements, the manufacturer must issue the individual a statement of eligibility, which is valid for 12 months and may be renewed. Under the bill, if an individual with a statement of eligibility and valid insulin prescription requests insulin from a pharmacy, the pharmacy must submit an order to the manufacturer, who must then provide a 90-day supply of insulin at no charge to the individual or pharmacy. The pharmacy may charge the individual a copayment of no more than $50. Under the bill, a manufacturer is not required to issue a statement of eligibility if the individual has prescription drug coverage through an individual or LRB-1423/1 JPC:all 2025 - 2026 Legislature SENATE BILL 50 group health plan and the manufacturer determines that the individual[s insulin needs are better addressed through the manufacturer[s copayment assistance program. In such case, the manufacturer must provide the individual with necessary drug coupons to submit to a pharmacy, and the individual may not be required to pay more than a $50 copayment for a 90-day supply of insulin. Under the bill, if the manufacturer determines that an individual is not eligible for the patient assistance program, the individual may file an appeal with OCI. The bill directs OCI to establish procedures for deciding appeals. Under the bill, OCI must issue a decision within 10 days, and that decision is final. The bill requires that insulin manufacturers annually report to OCI certain information, including the number of individuals served and the cost of insulin dispensed under the programs and that OCI annually report to the governor and the legislature on the programs. The bill also directs OCI to conduct public outreach and develop an information sheet about the programs, conduct satisfaction surveys of individuals and pharmacies that participate in the programs, and report to the governor and the legislature on the surveys by July 1, 2028. Additionally, the bill requires that OCI develop a training program for health care navigators to assist individuals in accessing appropriate long-term insulin options and maintain a list of trained navigators. The bill provides that a manufacturer that fails to comply with the bill[s provisions may be assessed a forfeiture of up to noncompliance, which increases to $400,000 per month if the manufacturer continues to be in noncompliance after six months and to $600,000 per month if the manufacturer continues to be in noncompliance after one year. The bill[s requirements do not apply to manufacturers with annual insulin sales revenue in Wisconsin of no more than $2,000,000 or to insulin that costs less than a specified dollar amount. Prescription Drug Affordability Review Board The bill creates a Prescription Drug Affordability Review Board, whose purpose is to protect Wisconsin residents and other stakeholders from the high costs of prescription drugs. The board consists of the commissioner of insurance and the following members, all of whom are appointed by the governor for four-year terms: 1. Two members who represent the pharmaceutical drug industry, at least one of whom is a licensed pharmacist. 2. Two members who represent the health insurance industry. 3. Two members who represent the health care industry, at least one of whom is a licensed practitioner. 4. Two members who represent the interests of the public. The bill requires the board to meet in open session at least four times per year to review prescription drug pricing information. The board must provide at least two weeks[ public notice of each meeting, make the meeting[s materials publicly available at least one week prior to the meeting, and provide the opportunity for LRB-1423/1 JPC:all $200,000 per month of 2025 - 2026 Legislature SENATE BILL 50 public comment. The bill imposes conflict of interest requirements for the board relating to recusal and public disclosure of certain conflicts. The bill directs the board to access and assess drug pricing information, to the extent practicable, by accessing and assessing information from other states, by assessing spending for the drug in Wisconsin, and by accessing other available pricing information. Under the bill, the board must conduct drug cost affordability reviews. The board must identify prescription drugs whose launch wholesale acquisition cost exceeds specified thresholds, prescription drugs whose increase in wholesale acquisition cost exceeds specified thresholds, and other prescription drugs that may create affordability challenges for the health care system in Wisconsin. For each identified prescription drug, the board must determine whether to conduct an affordability review by seeking stakeholder input and considering the average patient cost share for the drug. During an affordability review, the board must determine whether use of the prescription drug that is fully consistent with the labeling approved by the federal Food and Drug Administration or standard medical practice has led or will lead to an affordability challenge for the health care system in Wisconsin. In making this determination, the bill requires the board to consider a variety of factors, which include the following: 1. The drug[s wholesale acquisition cost. 2. The average monetary price concession, discount, or rebate the manufacturer provides, or is expected to provide, for the drug to health plans. 3. The total amount of price concessions, discounts, and rebates the manufacturer provides to each pharmacy benefit manager for the drug. 4. The price at which therapeutic alternatives have been sold and the average monetary concession, discount, or rebate the manufacturer provides, or is expected to provide, to health plan payors and pharmacy benefit managers for therapeutic alternatives. 5. The costs to health plans based on patient access consistent with federal labeled indications and recognized standard medical practice. 6. The impact on patient access resulting from the drug[s cost relative to insurance benefit design. 7. The current or expected dollar value of drug-specific patient access programs that are supported by the manufacturer. 8. The relative financial impacts to health, medical, or social services costs that can be quantified and compared to baseline effects of existing therapeutic alternatives. 9. The average patient copay or other cost sharing for the drug. If the board determines that a prescription drug will lead to an affordability challenge, the bill directs the board to establish an upper payment limit for that drug that applies to all purchases and payor reimbursements of the drug dispensed or administered to individuals in Wisconsin. In establishing the upper payment limit, the board must consider the cost of administering the drug, the cost of delivering it to consumers, and other relevant administrative costs. For certain LRB-1423/1 JPC:all 2025 - 2026 Legislature SENATE BILL 50 drugs, the board must solicit information from the manufacturer regarding the price increase and, if the board determines that the price increase is not a result of the need for increased manufacturing capacity or other effort to improve patient access during a public health emergency, the board must establish an upper payment limit equal to the drug[s cost prior to the price increase. Further, this bill provides $500,000 in program revenue in fiscal year 2026]27 for onetime implementation costs associated with establishing an Office of Prescription Drug Affordability in OCI. The bill provides that the Office of Prescription Drug Affordability is responsible for prescription drug affordability programming within OCI and for overseeing the operations of the Prescription Drug Affordability Review Board. Additionally, the bill authorizes and funds for fiscal year 2026]27 16.0 positions for the Office of Prescription Drug Affordability. Finally, the bill credits to the appropriation account for OCI[s general program operations all moneys received from the regulation of pharmacy benefit managers, pharmacy benefit management brokers, pharmacy benefit management consultants, pharmacy services administrative organizations, and pharmaceutical sales representatives. This proposal may contain a health insurance mandate requiring a social and financial impact report under s. 601.423, stats. For further information see the state fiscal estimate, which will be printed as an appendix to this bill. | In Committee |
| SJR10 | Proclaiming February 2025 as Black History Month. | Relating to: proclaiming February 2025 as Black History Month. | In Committee |
| AJR3 | Proclaiming January 2025 as Human Trafficking Awareness and Prevention Month in the state of Wisconsin. | Relating to: proclaiming January 2025 as Human Trafficking Awareness and Prevention Month in the state of Wisconsin. | In Committee |
| SJR3 | Proclaiming January 2025 as Human Trafficking Awareness and Prevention Month in the state of Wisconsin. | Relating to: proclaiming January 2025 as Human Trafficking Awareness and Prevention Month in the state of Wisconsin. | In Committee |
| Bill | Bill Name | Motion | Vote Date | Vote |
|---|---|---|---|---|
| SB10 | Access to public high schools for military recruiters. | Senate: Read a third time and passed | 06/18/2025 | Abstain |
| SB10 | Access to public high schools for military recruiters. | Senate: Senate Substitute Amendment 1 rejected | 06/18/2025 | Abstain |
| SB41 | School safety grants and making an appropriation. (FE) | Senate: Read a third time and passed | 06/18/2025 | Abstain |
| SB41 | School safety grants and making an appropriation. (FE) | Senate: Senate Amendment 2 rejected | 06/18/2025 | Abstain |
| SB41 | School safety grants and making an appropriation. (FE) | Senate: Senate Amendment 1 adopted | 06/18/2025 | Abstain |
| SB41 | School safety grants and making an appropriation. (FE) | Senate: Senate Substitute Amendment 1 rejected | 06/18/2025 | Abstain |
| AB85 | Recommendation to revoke extended supervision, parole, or probation if a person is charged with a crime. (FE) | Senate: Read a third time and concurred in | 06/18/2025 | Abstain |
| AB87 | Restitution orders following a conviction for human trafficking and restoration of the right to vote to a person barred from voting as a result of a felony conviction. (FE) | Senate: Read a third time and concurred in | 06/18/2025 | Abstain |
| SB108 | Sharing minors’ safety plans. (FE) | Senate: Read a third time and passed | 06/18/2025 | Abstain |
| SB108 | Sharing minors’ safety plans. (FE) | Senate: Senate Amendment 1 rejected | 06/18/2025 | Abstain |
| SB108 | Sharing minors’ safety plans. (FE) | Senate: Senate Substitute Amendment 1 rejected | 06/18/2025 | Abstain |
| SB94 | Civil action for injury or damages resulting from riot or vandalism, participation in a riot, prohibiting certain limitations or restrictions on law enforcement responses to riot or vandalism activity, and providing a penalty. | Senate: Read a third time and passed | 06/18/2025 | Abstain |
| SB111 | Transportation of minors for emergency detention. | Senate: Read a third time and passed | 06/18/2025 | Abstain |
| SB111 | Transportation of minors for emergency detention. | Senate: Senate Amendment 2 rejected | 06/18/2025 | Abstain |
| SB111 | Transportation of minors for emergency detention. | Senate: Senate Amendment 1 adopted | 06/18/2025 | Abstain |
| SB111 | Transportation of minors for emergency detention. | Senate: Senate Substitute Amendment 1 rejected | 06/18/2025 | Abstain |
| SB106 | Psychiatric residential treatment facilities, providing an exemption from emergency rule procedures, and granting rule-making authority. | Senate: Read a third time and passed | 06/18/2025 | Abstain |
| SB106 | Psychiatric residential treatment facilities, providing an exemption from emergency rule procedures, and granting rule-making authority. | Senate: Senate Amendment 2 rejected | 06/18/2025 | Abstain |
| SB106 | Psychiatric residential treatment facilities, providing an exemption from emergency rule procedures, and granting rule-making authority. | Senate: Senate Substitute Amendment 1 rejected | 06/18/2025 | Abstain |
| AB140 | Limitations on the total value of taxable property that may be included in a tax incremental financing district created in the city of Port Washington. (FE) | Senate: Read a third time and concurred in | 06/18/2025 | Abstain |
| SB179 | Applying the motor vehicle fuel tax supplier’s administrative allowance to diesel fuel, a motor vehicle fuel tax refund for evaporation losses, and making an appropriation. (FE) | Senate: Read a third time and passed | 06/18/2025 | Abstain |
| SB184 | Governmental restrictions based on the energy source of a motor vehicle or other device. | Senate: Read a third time and passed | 06/18/2025 | Abstain |
| SB182 | Emergency medical services education, tuition and materials reimbursement for emergency medical responders and emergency medical services practitioners, and a live 911 pilot program. (FE) | Senate: Read a third time and passed | 06/18/2025 | Abstain |
| SB182 | Emergency medical services education, tuition and materials reimbursement for emergency medical responders and emergency medical services practitioners, and a live 911 pilot program. (FE) | Senate: Senate Amendment 2 rejected | 06/18/2025 | Abstain |
| SB182 | Emergency medical services education, tuition and materials reimbursement for emergency medical responders and emergency medical services practitioners, and a live 911 pilot program. (FE) | Senate: Senate Substitute Amendment 1 rejected | 06/18/2025 | Abstain |
| SB232 | Grants to child advocacy centers. (FE) | Senate: Read a third time and passed | 06/18/2025 | Abstain |
| AB269 | Delivery network couriers and transportation network drivers, Department of Financial Institutions’ approval to offer portable benefit accounts, providing for insurance coverage, modifying administrative rules related to accident and sickness insurance, and granting rule-making authority. (FE) | Senate: Read a third time and concurred in | 06/18/2025 | Abstain |
| SB278 | Sunset of the community-oriented policing-house grant program. | Senate: Read a third time and passed | 06/18/2025 | Abstain |
| SB279 | Grants to law enforcement agencies for data-sharing platforms. | Senate: Read a third time and passed | 06/18/2025 | Abstain |
| SB283 | Public protective services hearing protection assistance. (FE) | Senate: Read a third time and passed | 06/18/2025 | Abstain |
| SB283 | Public protective services hearing protection assistance. (FE) | Senate: Senate Amendment 2 rejected | 06/18/2025 | Abstain |
| SB283 | Public protective services hearing protection assistance. (FE) | Senate: Senate Substitute Amendment 1 rejected | 06/18/2025 | Abstain |
| SR5 | Notifying the assembly and the governor that Timothy La Sage is elected senate sergeant at arms of the 2025-2026 senate. | Senate: Adopted | 06/18/2025 | Abstain |
| SR5 | Notifying the assembly and the governor that Timothy La Sage is elected senate sergeant at arms of the 2025-2026 senate. | Senate: Refused to refer to committee on Senate Organization | 06/18/2025 | Abstain |
| SB33 | Representations depicting nudity and providing a penalty. | Senate: Read a third time and passed | 05/15/2025 | Yea |
| SB56 | The use of federal capitalization grant funds for lead service line replacement. (FE) | Senate: Read a third time and passed | 05/15/2025 | Nay |
| SB56 | The use of federal capitalization grant funds for lead service line replacement. (FE) | Senate: Decision of the Chair stands as the judgment of the Senate | 05/15/2025 | Nay |
| SB56 | The use of federal capitalization grant funds for lead service line replacement. (FE) | Senate: Senate Substitute Amendment 1 rejected | 05/15/2025 | Nay |
| AB73 | Statutory recognition of specialized treatment court and commercial court dockets. | Senate: Read a third time and concurred in | 05/15/2025 | Nay |
| AB73 | Statutory recognition of specialized treatment court and commercial court dockets. | Senate: Decision of the Chair stands as the judgment of the Senate | 05/15/2025 | Nay |
| SB96 | Exempting certain electric vehicle charging stations located at a residence from the electric vehicle charging tax. (FE) | Senate: Read a third time and passed | 05/15/2025 | Yea |
| SB125 | A nuclear power siting study and time limits for taking final action on certain certificate of public convenience and necessity applications. (FE) | Senate: Read a third time and passed | 05/15/2025 | Yea |
| SB125 | A nuclear power siting study and time limits for taking final action on certain certificate of public convenience and necessity applications. (FE) | Senate: Decision of the Chair stands as the judgment of the Senate | 05/15/2025 | Nay |
| SB146 | Prohibiting persons who have been convicted of a violent crime from changing their name and providing a penalty. | Senate: Read a third time and passed | 05/15/2025 | Nay |
| SJR48 | Congratulating Knights of Columbus Council 499 for achieving a century of compassionate commitment to service of the Church, their community, and their fellow man. | Senate: Adopted | 05/15/2025 | Yea |
| SB23 | Extension of eligibility under the Medical Assistance program for postpartum women. (FE) | Senate: Read a third time and passed | 04/22/2025 | Yea |
| SB24 | Limitations on the total value of taxable property that may be included in, and the lifespan of, a tax incremental financing district created in the city of Middleton. (FE) | Senate: Read a third time and passed | 04/22/2025 | Yea |
| SB66 | Registration plate concealment devices and providing a penalty. | Senate: Read a third time and passed | 04/22/2025 | Yea |
| SB66 | Registration plate concealment devices and providing a penalty. | Senate: Senate Amendment 1 rejected | 04/22/2025 | Nay |
| SB76 | Dismissing or amending certain criminal charges and deferred prosecution agreements for certain crimes. | Senate: Read a third time and passed | 04/22/2025 | Nay |
| SR3 | Notifying the assembly and the governor that Cyrus Anderson is elected senate chief clerk of the 2025-2026 senate. | Senate: Adopted | 04/22/2025 | Yea |
| SB5 | Battery or threat to jurors and providing a penalty. | Senate: Read a third time and passed | 03/18/2025 | Yea |
| SB4 | Agreements for direct primary care. | Senate: Read a third time and passed | 03/18/2025 | Nay |
| SB4 | Agreements for direct primary care. | Senate: Senate Amendment 1 rejected | 03/18/2025 | Nay |
| AB1 | Changes to the educational assessment program and the school and school district accountability report. (FE) | Senate: Read a third time and concurred in | 03/18/2025 | Nay |
| SB25 | Court-issued criminal complaints in officer-involved deaths. | Senate: Read a third time and passed | 03/18/2025 | Nay |
| SJR7 | Recognizing that the Wisconsin State Legislature supports nuclear power and fusion energy as clean energy sources that are critical to safely meeting Wisconsin’s growing energy demands and declaring the legislature’s commitment to the continuation and expansion of nuclear power and nuclear technologies, the development of nuclear technologies and fusion energy, and employing the leadership and resources necessary to support the development of and investment in nuclear power, fusion energy, and r | Senate: Adopted | 03/18/2025 | Nay |
| AB96 | Ratification of the agreement negotiated between the Board of Regents of the University of Wisconsin System and the Wisconsin State Building Trades Negotiating Committee, for the 2024-25 fiscal year, covering employees in the building trades crafts collective bargaining unit, and authorizing an expenditure of funds. (FE) | Senate: Read a third time and concurred in | 03/18/2025 | Yea |
| AB94 | Ratification of the agreement negotiated between the State of Wisconsin and the Wisconsin State Building Trades Negotiating Committee, for the 2024-25 fiscal year, covering employees in the building trades crafts collective bargaining unit, and authorizing an expenditure of funds. (FE) | Senate: Read a third time and concurred in | 03/18/2025 | Yea |
| AB95 | Ratification of the agreement negotiated between the University of Wisconsin-Madison and the Wisconsin State Building Trades Negotiating Committee, for the 2024-25 fiscal year, covering employees in the building trades crafts collective bargaining unit, and authorizing an expenditure of funds. (FE) | Senate: Read a third time and concurred in | 03/18/2025 | Yea |
| SJR2 | Requiring photographic identification to vote in any election (second consideration). | Senate: Read a third time and adopted | 01/08/2025 | Nay |
| SR1 | Notifying the assembly and the governor that the 2025-2026 senate is organized. | Senate: Adopted | 01/06/2025 | Nay |
| SJR1 | The session schedule for the 2025-2026 biennial session period. | Senate: Adopted | 01/06/2025 | Nay |
| Committee | Position | Rank | |
|---|---|---|---|
| Detail | Wisconsin Joint Finance Committee | 7 | |
| Detail | Wisconsin Joint Legislative Council | 10 | |
| Detail | Wisconsin Senate Finance Committee | 1 | |
| Detail | Wisconsin Senate Judiciary and Public Safety Committee | 2 | |
| Detail | Wisconsin Senate Mental Health, Substance Abuse Prevention, Children and Families Committee | 2 |
| State | District | Chamber | Party | Status | Start Date | End Date |
|---|---|---|---|---|---|---|
| WI | Wisconsin Senate District 06 | Senate | Democrat | In Office | 01/02/2017 | |
| WI | Wisconsin Assembly District 17 | Assembly | Democrat | Out of Office | 01/01/2013 | 01/16/2024 |